Annual Report

MedPlus Health Services Private Limited
Standalone Financial Statements for period 01/04/2015 to 31/03/2016
[400100] Disclosure of general information about company

Unless otherwise specified, all monetary values are in INR
01/04/2015 01/04/2014
to to
31/03/2016 31/03/2015
MedPlus Health Services
Name of company Private Limited
Corporate identity number U85110TG2006PTC051845
Permanent account number of entity AAECM9412H
707, 7th Floor,
5-9-13 Taramandal
Address of registered office of company Commercial Complex,
Saifabad Hyderabad Hyderabad Telangana 500004
India
Commercial and
Type of industry Industrial
Date of board meeting when final accounts were approved 28/05/2016
01-04-2014 To
Period covered by financial statements 01-04-2015 To 31-03-2016
31-03-2015
Date of start of reporting period 01/04/2015 01/04/2014
Date of end of reporting period 31/03/2016 31/03/2015
Nature of report standalone consolidated Standalone
Content of report Financial Statements
Description of presentation currency INR
Level of rounding used in financial statements Actual
Type of cash flow statement Indirect Method
Whether company is maintaining books of account and other
No
relevant books and papers in electronic form
Whether books of account and other books and papers are
maintained No
on cloud
Disclosure of principal product or services [Table] ..(1)

Types of principal product or services [Axis] Column 1
01/04/2015
to
31/03/2016
Disclosure of general information about company [Abstract]
Disclosure of principal product or services [Abstract]
Disclosure of principal product or services [LineItems]
Product or service category (ITC 4 digit) code 9993
Medical laboratory
Description of product or service category services
Turnover of product or service category 2,24,39,160
Highest turnover contributing product or service (ITC 8 digit) code 99931950
Medical laboratory
Description of product or service services
Turnover of highest contributing product or service 2,24,39,160
MedPlus Health Services Private Limited Standalone Financial Statements for period 01/04/2015 to 31/03/2016
[400400] Disclosures - Directors report
Details of directors signing board report [Table] ..(1)

Directors signing board report [Axis] Column 1 Column 2
01/04/2015 01/04/2015
to to
31/03/2016 31/03/2016
Details of signatories of board report [Abstract]
Details of directors signing board report [LineItems]
Name of director signing board report [Abstract]
First name of director GANGADI CHERUKUPALLI
Middle name of director MADHUKAR BHASKAR
Last name of director REDDY REDDY
Designation of director Managing Director Director
Director identification number of director 00098097 00926550
Date of signing board report 06/09/2016 06/09/2016
2

01/04/2015
to
31/03/2016
Textual information (1)
Disclosure in board of directors report explanatory [TextBlock] [See below]
Your Company is
considering expanding
Description of state of companies affair its capacities from the
existing level to further
improve the performance.
The Company doesn’t have
any profits as on 31st
March, 2016, the
directors have
Disclosure relating to amounts if any which is proposed to carry to any
transferred the loss
reserves component after tax to
reserves during the
financial year under
review.
Your Directors doesn’t
propose any dividend
Disclosures relating to amount recommended to be paid as dividend during the financial year
under review
Details regarding energy conservation [See below]
Details regarding technology absorption [See below]
Details regarding foreign exchange earnings and outgo [See below]
Disclosures in director’s responsibility statement [See below]
There are no significant
material changes and
commitments affecting
Details of material changes and commitment occurred during period
financial position
affecting financial position of company between 31st March, 2016
and the date of Board’s
Report.
Particulars of loans guarantee investment under section 186 [TextBlock] [See below]
Particulars of contracts/arrangements with related parties under section Textual information (7)
188(1) [TextBlock] [See below]
Whether there are contracts/arrangements/transactions not at arm's
No
length basis
Whether there are material contracts/arrangements/transactions at
No
arm's length basis
Disclosure of extract of annual return as provided under section 92(3) Textual information (8)
[TextBlock] [See below]
Disclosure of statement on declaration given by independent directors Textual information (9)
under section 149(6) [TextBlock] [See below]
Disclosure for companies covered under section 178(1) on
directors appointment and remuneration including other matters [See below]
provided under section 178(3) [TextBlock]
Disclosure of statement on development and implementation of risk Textual information (11)
management policy [TextBlock] [See below]
Details on policy development and implementation by company on
corporate social responsibility initiatives taken during year NA
[TextBlock]
Disclosure as per rule 8(5) of companies accounts rules 2014 [TextBlock]
Disclosure of financial summary or highlights [TextBlock] [See below]
There has
been no change in the
nature of business of the
Disclosure of change in nature of business [TextBlock] Company during the
financial year under
review.
Details of directors or key managerial personnels who were Textual information (13)
appointed or have resigned during year [TextBlock] [See below]
Disclosure of companies which have become or ceased to be its
subsidiaries, joint ventures or associate companies during NA
year [TextBlock]
Details relating to deposits covered under chapter v of companies act Textual information (14)
3
t h e
details of deposits which
are not in compliance with
Details of deposits which are not in compliance with requirements
the requirements of
of chapter v of act [TextBlock] Chapter V of the
A c t :
Nil.
There are
Details of significant and material orders passed by no significant and
material orders that were
regulators or courts or tribunals impacting going concern passed by the regulators
status and company’s operations in future [TextBlock] or courts or tribunals
against your Company.
Details regarding adequacy of internal financial controls with Textual information (15)
reference to financial statements [TextBlock] [See below]
Disclosure of appointment and remuneration of managerial personnels Textual information (16)
Number of meetings of board [pure] 0
4
Disclosure in board of directors report explanatory [Text Block]

Board’s report
To
The Members
Hyderabad.
Your Directors have pleasure in presenting the Annual Report together with the Financial Statement for the financial year from 1st April, 2015 to
31st March, 2016 along with the Report of Directors including annexure thereto and Report of Auditor's thereon.
1. STATEMENT OF AFFAIRS:
The Company’s financial performance for the financial year ended as on 31st March, 2016 is summarized below:
Amount (In Rs)
Particulars 31st March, 2016 31st March, 2015
Income from Operations (Including other Income) 32,500,434 36,376,939
Total Expenses 75,536,193 70,213,893
Profit/Loss before Tax (43,035,759) (52,019,410)
Profit/Loss after Tax (43,035,759) (52,019,410)
Balance carried to Balance sheet (43,035,759) (52,019,410)
5
1.1 PERFORMANCE AND FINANCIAL HIGHLIGHTS:
During the financial year ended as on 31st March, 2016, the Company recorded a total revenue of 325.00 Lakhs (Previous financial year 363.76
Lakhs) and recorded net loss (after considering an amount towards depreciation in accordance with provisions of Schedule II of the Companies
Act, 2013) of 430.35 Lakhs (Previous Year loss of 520.19 Lakhs).
1.2 FUTURE OUTLOOK:
Your Company is considering expanding its capacities from the existing level to further improve the performance.
2 EVENTS SUBSEQUENT TO THE DATE OF FINANCIAL STATEMENTS TILL THE DATE OF DIRECTORS REPORT:
There are no significant material changes and commitments affecting financial position between 31st March, 2016 and the date of Board’s Report.
3 CHANGE IN THE NATURE OF BUSINESS, IF ANY:
Your Company has not changed the nature of Business during the financial year under review.
4 DIVIDEND:
Your Directors doesn’t propose any dividend during the financial year under review.
5 TRANSFER TO RESERVES:
The Company doesn’t have any profits as on 31st March, 2016, the directors have transferred the loss component after tax to reserves during the
financial year under review.
6 BOARD MEETINGS:
6 (Six) Board Meetings were held during the year, the details of the same are given below:
6
Date of Board Meetings
1. 22nd April 2015
2. 28th May 2015
3. 8th September 2015
4. 2nd November 2015
5. 13th November 2015
6. 28th January 2016
Number of Board Meetings attended by each Director during the financial year 2015-16:
S. No. Name of Director Designation No. of Board Meetings attended
1. Mr. G. Madhukar Reddy Managing Director 6
2. Mr. Cherukupalli Bhaskar Reddy Director 6
3. Mr. Roy Edwin Campbell II Nominee Director 1
4. Ms. Sudha Ravi Nominee Director 4
7 COMMITTEE MEETINGS:
The following is the Committee constituted by the Company:
7
Audit Committee: Audit Committee of the Company has met thrice on. 28th May 2015, 8th September 2015 and 13th November 2015
Composition Designation No. of Meetings held No. of Meetings attended
Mr. G. Madhukar Reddy Member 3 3
Mr. Roy Edwin Campbell II Member 3 1
Ms. Sudha Ravi Member 3 3
*All the recommendations made by the Audit Committee were accepted by the Board.
Remuneration and compensation committee: Remuneration and Compensation Committee of the Company has met thrice on 31st May 2015, 1st
October 2015 & 28th January 2016.
Composition Designation No. of Meetings held No. of Meetings attended
Mr. G. Madhukar Reddy Member 3 3
Mr. Roy Edwin Campbell II Member 3 0
*Ms. Sudha Ravi Member 3 3
8 DIRECTORS AND KEY MANAGERIAL PERSONNEL:
Following are the Directors and Key Managerial Personnel of the Company as on date:
8
S. No. Name of Director Designation
1. Mr. G. Madhukar Reddy Managing Director
2. Mr. Cherukupalli Bhaskar Reddy Director
3. Mr. Roy Edwin Campbell II Nominee Director
4. Ms. Sudha Ravi Nominee Director
5. Mr. Atul Kumar Agarwal Chief Financial Officer
6. Mr. Parag Kumar Jain Company Secretary
Appointment :
Following are the particulars of appointments and re-appointments of the Directors and Key Managerial Personnel of your Company during the
Financial Year 2015-16:
Mr. Atul Kumar Agarwal was appointed as Chief Financial Officer of the Company on 28th January, 2016.
9 STATEMENT ON DECLARATION GIVEN BY THE INDEPENDENT DIRECTORS:
Since the Company is a Listed Private Company, appointment of Independent directors as per sub section (4) of section 149 of the Companies
Act, 2013, is not mandatory to your Company.
10 CHANGES IN SHARE CAPITAL:
There was no change in the capital structure during the year.
11 DIRECTOR’S RESPONSIBILITY STATEMENT:
9
Pursuant to Section134 (5) of the Companies Act, 2013, the Directors confirm that:
(i) In the preparation of the annual accounts for the year ended 31st March, 2016 the applicable accounting standards had been followed
along with proper explanation relating to material departures;
(ii) the directors had selected such accounting policies and applied them consistently and made judgments and estimates that are reasonable
and prudent so as to give a true and fair view of the state of affairs of the company at the end of the financial year 31st March, 2016 and of the
profits of the company for that period;
(iii) the directors had taken proper and sufficient care for the maintenance of adequate accounting records in accordance with the provisions of
this Act for safeguarding the assets of the company and for preventing and detecting fraud and other irregularities;
(iv) the directors had prepared the annual accounts for the period ended 31st March, 2016 on a going concern basis.
(v) that the directors have laid down internal controls to be followed by the Company and that such internal financial controls are adequate
and were operating effectively;
(vi) the directors had devised proper systems to ensure compliance with the provisions of all applicable laws and that such systems were
adequate and operating effectively.
12 NAMES OF THE SUBSIDIARIES/ASSOCIATES/JOINT VENTURES:
The following are the Subsidiaries of your Company:
· Optival Health Solutions Private Limited
· Ritemed Pharma Retail Private Limited
· MHS Pharmaceuticals Private Limited
10
· PanIndia Pharma Distributors Private Limited
· Ritecure Pharma Private Limited
· Medsupply Distributors Private Limited
The following are the step subsidiaries of your Company:
· Sai Sridhar Pharma Private Limited
· Venkata Krishna Enterprises Private Limited
· Shri Banashankari Pharma Private Limited
· Deccan Medisales Private Limited
· Sidson Pharma Distributors Private Limited
13 PERFORMANCE & FINANCIAL POSITION OF SUBSIDIARIES:
M/s. Optival Health Solutions Private Limited: The following table indicates the financial position of the Company:
Income from Operations (Including other Income) 16,670,419,101 13,077,905,337
Total Expenses 16,561,873,212 12,971,083,228
Profit/Loss before Tax 108,545,889 106,822,109
Profit/Loss after Tax 59,094,882 67,341,223
Balance carried to Balance sheet 59,094,882 67,341,223
11
M/s. Ritemed Pharma Retail Private Limited: The following table indicates the financial position of the Company:
Total Expenses 4,254,332,190 3,215,680,357
M/s. MHS Pharmaceuticals Private Limited: The following table indicates the financial position of the Company:
Total Expenses 348,332,411 242,831,249
M/s. PanIndia Pharma Distributors Private Limited: The following table indicates the financial position of the Company:
12
Income from Operations (Including other Income) 187,715 2,513
Total Expenses 289,945 502,306
Profit/Loss before Tax (102,230) (499,793)
Profit/Loss after Tax (140,485) (499,793)
Balance carried to Balance sheet (140,485) (499,793)
M/s. Ritecure Pharma Private Limited: The following table indicates the financial position of the Company:
Income from Operations (Including other Income) - -
Total Expenses 33,704 24,867
Profit/Loss before Tax (33,704) (24,867)
Profit/Loss after Tax (33,704) (24,867)
Balance carried to Balance sheet (33,704) (24,867)
M/s. Medsupply Distributors Private Limited: The following table indicates the financial position of the Company:
Total Expenses 1,662,093 29,399,403
13
Profit/Loss before Tax (619,304) (15,120,870)
Profit/Loss after Tax (619,304) (15,120,870)
Balance carried to Balance sheet (619,304) (15,120,870)
M/s. Sai Sridhar Pharma Private Limited: The following table indicates the financial position of the Company:
Particulars Amount (In Rs) Amount (In Rs)
31st March, 2016 31st March, 2015
Income from Operations (Including other Income) 1,132,149,365 887,052,682
Total Expenses 1,120,511,580 879,482,241
Profit before Tax 11,637,785 7,570,441
Profit after Tax 7,523,849 5,218,319
Balance carried to Balance Sheet 7,523,849 5,218,319
M/s. Venkata Krishna Enterprises Private Limited: The following table indicates the financial position of the Company:
Total Expenses 1,397,771,352 1,070,396,165
14
Profit after Tax 6,639,441 4,215,512
M/s. Shri Banashankari Pharma Private Limited: The following table indicates the financial position of the Company:
Total Expenses 136,640,612 41,851,788
Profit before Tax (1,724) (574,216)
Profit after Tax (1,724) (574,216)
Balance carried to Balance Sheet (1,724)) (574,216)
M/s. Deccan Medisales Private Limited: The following table indicates the financial position of the Company:
Total Expenses 761,608,535 450,222,127
15
Profit after Tax 5,090,501 2,341,854
M/s. Sidson Pharma Distributors Private Limited: The following table indicates the financial position of the Company:
Total Expenses 230,602,629 134,890,763
Profit before Tax (9,624,148) (6,154,636)
Profit after Tax (9,624,148) (6,154,636)
Balance carried to Balance Sheet (9,624,148) (6,154,636)
14 EXTRACT OF ANNUAL RETURN:
As required pursuant to Section 92(3) of the Companies Act, 2013 and rule 12(1) of the Companies (Management and Administration) Rules,
2014, an extract of Annual Return in Form MGT-9 as a part of this Report is annexed to this report as ( Annexure - I).
15 CONSERVATION OF ENERGY, TECHNOLOGY ABSORPTION AND FOREIGN EXCHANGE EARNINGS &OUTGO:
As required by the provisions of Companies Act, 2013, the relevant information pertaining to conservation of energy, technology absorption and
foreign exchange earnings and outgo are given under:
15.1 CONSERVATION OF ENERGY:
16
· Steps taken on Conservation of Energy and impact thereof: Conservation of energy is an ongoing process in the Company. Every effort is
made towards optimum utilization of energy. Efforts are also directed towards eliminating wastage in all areas of operations.
· Steps taken by the company for utilizing alternate sources of energy: Nil.
· Capital investment on energy conservation equipment: There are no substantial additional investments and proposals for reduction in
energy consumption at present. The same will be undertaken as and when necessary by the Company.
15.2 TECHNOLOGY ABSORPTION:
i) Efforts were made towards technology absorption: Nil
ii) benefits derived as a result of the above efforts, e.g. product improvement, cost reduction, product development, import substitution: Nil
iii) In case of imported technology (imported during the last 3 years reckoned from the beginning of the financial year), following information
may be furnished:
a) Details of technology imported - Nil
b) Year of import - Nil
c) Whether the technology been fully absorbed - Nil
d) If not fully absorbed, areas where absorption has not taken
e) place, and the reasons therefore - Nil
iv) Expenditure incurred on Research and Development - Nil
15.3 FOREIGN EXCHANGE EARNINGS & OUTGO:
During the year under review, the Company has the following Foreign Exchange Earnings & Outgo:
(Amount in Rs)
S. No. Particulars As on 31st March, 2016 As on 31st March, 2015
1. Foreign Exchange Earnings Nil Nil
2. Foreign Exchange Outgo Nil Nil
17
16 DETAILS RELATING TO DEPOSITS:
The Company doesn’t have any deposits as covered under chapter V of the Companies Act, 2013, following are the disclosures:
· Deposits accepted during the year : Nil
· remained unpaid or unclaimed as at the end of the year : Nil
· whether there has been any default in repayment of deposits or payment of interest thereon during the year and if so, number of such cases
and the total amount involved -
(i) at the beginning of the year; Nil
(ii) maximum during the year; Nil
(iii) at the end of the year; Nil
the details of deposits which are not in compliance with the requirements of Chapter V of the Act : Nil.
17 EXPLANATIONS OR COMMENTS BY THE BOARD ON EVERY QUALIFICATION, RESERVATION OR ADVERSE REMARK

OR DISCLAIMER MADE BY THE AUDITOR IN HIS REPORT:
Auditors Qualification Management Reply
The Company has utilized the money raised by way of the term loans during the
previous year for the purposes for which they were raised, except for:
Nature of Funds raised : Term Loan in form of Non Convertible Debentures
Details of Default : Funds used for working capital requirements/funding of losses of Because of non-availability of funds, the
the Company Company was compelled to utilise the
funds meant for investment purpose in
order to manage the day to day operations
of the Company.
Amount : Rs. 40,927,527/-
Also idle/surplus funds which were not required for immediate utilization have been
gainfully invested in liquid investments payable on demand. The maximum amount
of idle/surplus funds invested during the year was Rs. 300,594,839, of which Rs.
17,342,483 (lying in bank current and deposit accounts) was outstanding at the end
of the year.
18
18 DETAILS IN RESPECT OF FRAUDS REPORTED BY AUDITORS UNDER SUB - SECTION (12) OF SECTION 143:
The Auditors have not reported any offence involving fraud committed against the Company by the officers or employees of the Company under
sub section (12) of section 143 to the Audit Committee or the Board.
19 SIGNIFICANT & MATERIAL ORDERS PASSED BY THE REGULATORS, COURTS AND TRIBUNALS IMPACTING THE
GOING CONCERN STATUS AND COMPANY’S OPERATIONS IN FUTURE:
There are no significant and material orders that were passed by the regulators or courts or tribunals against your Company.
20 ADEQUACY OF INTERNAL FINANCIAL CONTROLS WITH REFERNECE TO THE FINANCIAL STATEMENTS:
Your Company has effective ‘internal financial controls’ that ensure an orderly and efficient conduct of its business, including adherence to
company’s policies, safeguarding of its assets, prevention and detection of frauds and errors, accuracy and completeness of the accounting
records, and timely preparation of reliable financial information.
While these controls have been effective through-out the year, these are reviewed on a periodic basis for any changes/ modifications to align to
business needs.
21 CRITERIA FOR DETERMINING QUALIFICATIONS, POSITIVE ATTRIBUTES AND INDEPENDENCY OF A DIRECTOR:
There are no Independent Directors on Board of the Company.
21.1 APPOINTMENT AND QUALIFICATIONS:
The general terms of appointment of Directors, KMP and Senior Managerial personnel is provided hereunder:
F They are identified and ascertained based on the integrity, qualification, expertise and experience for appointment as Director, KMP or at Senior
Management level and the Board decides whether qualification, expertise and experience possessed by a person are sufficient / satisfactory for the
19
concerned position
21.2 TERM/TENURE:
v Managing Director/Whole-Time Director/Manager (Managerial Person):
F The Company has a policy not to appoint or re-appoint any person as Managerial Person for a term exceeding 5 years at a time.
21.3 REMUNERATION:
The Company’s Remuneration Strategy is designed to attract and retain quality talent that gives its business a competitive advantage and enables
the Company to achieve its objectives. The Company’s Remuneration Strategy, whilst focusing on remuneration and related aspects of
performance management, is aligned with and reinforces the employee value proposition of a superior quality of work life, that includes an
enabling work environment, an empowering and engaging work culture and opportunities to learn and grow. The Compensation approach
endeavours to align each employee with the Company’s goals.
v Remuneration to Key Managerial Personnel (“KMP”):
a) Remuneration of KMP is determined, recommended by the Remuneration Committee and is approved by the Board. Remuneration of the
Managing Director / Whole time Director is also subject to the approval of the shareholders.
b) Remuneration is reviewed and revised periodically, when such a revision is warranted by the market.
c) Apart from fixed elements of remuneration and benefits, the KMP are also eligible for Variable Pay / Performance Bonus which is linked
to their individual performance and the overall performance of the Company.
v Remuneration of employees other than KMP:
a) Remuneration of employees other than KMP is approved by the Board.
20
b) Remuneration is reviewed and revised periodically, when such a revision is warranted by the market. The quantum of revision is linked to
market trends, the competitive context of the Company’s business, as well as the track record of the individual employee.
22 ANNUAL EVALUATION OF PERFORMANCE BY THE BOARD:
Pursuant to the provisions of the Companies Act, 2013, evaluation of all Board members, annual performance evaluation of its own performance,
as well as the evaluation of the working of its Committees of the Board is led by the Chairman of the Board with specific focus on the
performance and effective functioning of the Board.
The evaluation process also considers the time spent by each of the Board members, core competencies, personal characteristics, accomplishment
of specific responsibilities and expertise.
23 RATIO OF REMUNERATION OF EACH OF THE DIRECTOR TO THE MEDIAN EMPLOYEE’S REMUNERATION:
As per Annexure.
24 PARTICULARS OF LOANS, GUARANTEES OR INVESTMENTS MADE BY THE COMPANY:
Particulars relating to loan or guarantee to any person or body corporate made by the Company during the Financial Year pursuant to Section 186
of Companies Act, 2013 is as follows:
Investment in Equity shares of its Subsidiaries
In Rs Millions
S. No. Name of the Subsidiary 31st March, 2016 31st March, 2015
1. Optival Health Solutions Private Limited 1,415.27 1,185.27
2. Ritemed Pharma Retail Private Limited 230.00 230.00
3. MHS Pharmaceuticals Private Limited 0.10 0.10
4. PanIndia Pharma Distributors Private Limited 43.60 26.60
21
5. Ritecure Pharma Private Limited 0.10 0.10
6. Medsupply Distributors Private Limited 125.77 125.77
7. Sai Sridhar Pharma Private Limited (through its Subsidiary) 0.24 0.24
8. Venkata Krishna Enterprises Private Limited (through its Subsidiary) 0.18 0.18
9. Shri Banashankari Pharma Private Limited (through its Subsidiary) 2.10 2.10
10. Deccan Medisales Private Limited (through its Subsidiary) 2.10 2.10
11. Sidson Pharma Distributors Private Limited (through its Subsidiary) 20.10 Nil
Loans given
The Company has not given any loans during this financial year.
Corporate Guarantee given
(Rs. In Millions)
1. Ritemed Pharma Retail Private Limited - 180.00
2. Optival Health Solutions Private Limited - 750.00
25 RISK MANAGEMENT:
22
As a diversified enterprise, your Company continues to focus on a system-based approach to business risk management. The management of risk
is embedded in the corporate strategies of developing a portfolio of world-class businesses that best match organizational capability with market
opportunities, focusing on building distributed leadership and succession planning processes, nurturing specialism and enhancing organisational
capabilities through timely developmental inputs.
The Company has initiated procedure for risk assessment and its minimization.
26 PARTICULARS OF EMPLOYEES:
Pursuant to Rule 5 pursuant to the Companies (Appointment and Remuneration Managerial Personnel) Rule, 2014 of the Companies Act, 2013,
there are no employees who are in receipt of remuneration exceeding Rs. 1,02,00,000/- or more per annum or Rs. 8,50,000/- or more per month or
where employed for a part of the year during the financial year under review .
27 SECRETARIAL AUDITORS:
The Board has appointed M/s R. & A Associates, a firm of practicing Company Secretaries, Hyderabad as the Secretarial Auditor to conduct
Secretarial Audit of the Company for the financial year ended 31st March, 2016 in compliance with the provisions of Section 204 of the
Companies Act, 2013.
The report of the Secretarial Audit Report by M/s. R & A Associates, in Form MR-3 is enclosed as ( Annexure - II) to this Report.
28 STATUTORY AUDITORS:
M/s. S. R. Batliboi & Associates LLP, (FRN: 101049W) Chartered Accountants are the Statutory Auditors of the Company. As per the provisions
of the Companies Act, 2013, it is recommended to ratify the appointment of auditor till the conclusion of next Annual General Meeting of the
Company.
29 Debenture Trustee
Your Company has appointed IL & FS Trust Company Limited as Debenture Trustee of the Company for the Non Convertible Debentures listed
in the Bombay Stock Exchange. The details as under
IL & FS Trust Company Limited
Address: The IL&FS Financial Centre, Plot No. C-22, G-Block, Bandra Kurla Complex, Bandra (East), Mumbai - 400 051.
23
Tel: +91 22 26533333
Fax: +91 22 2653 3297
Email: itcl@ilfsindia.com
Website: www.itclindia.com
30 RELATED PARTY TRANSACTIONS:
The contracts/arrangements with related parties as specified in sub section (1) of section 188 of the Companies Act, 2013 during the financial year
2015-16, is attached as Form AOC-2 to this report as ( Annexure - III).
31 ANNUAL DISCLOSURE AS PER DEBENTURE LISTING AGREEMENT:
S. No. Particulars Amount
1. Loans and advances in the nature of loans to subsidiaries
- Ritemed Pharma Retail Private Limited (Short-term Loan taken) 30,000,000
- Ritemed Pharma Retail Private Limited (Short-term Loan repaid) 30,000,000
2. Loans and advances in the nature of loans to Associates Nil
3. Loans and advances in the nature of loans to Firm/Companies in which directors are interested
32 DISCLOSURE UNDER THE SEXUAL HARASSMENT OF WOMAN AT WORKPLACE (PREVENTION, PROHIBITION AND
REDRESSAL) ACT, 2013:
As required under the Harassment Act, the following is a summary of sexual harassment during the financial year 2015 - 2016:
S. No. Particulars Remarks
24
1. Number of sexual harassment complaints received in a year. Nil
2. Number of complaints disposed off during the year. Nil
3. Number of cases pending for more than 90 days. Nil
4. Number of awareness programs or workshops against sexual harassment conducted during the year. Nil
5. Nature of action taken by the employer or district officer with respect to the cases. Nil
33 CHANGE IN ACCOUNTING POLICY.
There was no change in the accounting policy of the Company.
34 VIGIL MECHANISM/WHISTLE BLOWER POLICY :
The Board of Directors of the Company have adopted Whistle Blower Policy. This policy is formulated to provide an opportunity to employees
and an avenue to raise concerns and to access in good faith the Audit Committee, to the highest possible standards of ethical, moral and legal
business conduct and its commitment to open communication, in case they observe unethical and improper practices or any other wrongful
conduct in the Company, to provide necessary safeguards for protection of employees from reprisals or victimization and to prohibit managerial
personnel from taking any adverse personnel action against those employees.
35 DETAILS OF ADEQUACY OF INTERNAL FINANCIAL CONTROLS
The Company has in place adequate internal financial controls with reference to financial statements. During the year, such controls were tested
and no reportable material weakness in the design or operation were observed
36 CHANGE IN THE NATURE OF BUSINESS
There has been no change in the nature of business of the Company during the financial year under review.
37 DECLARATION WITH THE COMPLIANCE WITH THE CODE OF CONDUCT BY MEMBERS OF THE BOARD AND SENIOR
MANAGEMENT PERSONNEL
25
The Company has complied with the requirements about code of conduct for Board members and Sr. Management Personnel .
38 ACKNOWLEDGEMENTS:
The Board wishes to place on record its grateful thanks for the assistance and support extended by all Government Authorities, Banks,
shareholders and consultants of the Company.
Your directors express their appreciation for the dedicated and sincere services rendered by the employees of the Company.
BY ORDER OF THE BOARD
CIN: U85110AP2006PTC051845
Place : Hyderabad [G. Madhukar Reddy] [C. Bhaskar Reddy]
Date: 06/09/2016 Managing Director Director
DIN: 00098097 DIN: 00926550
26
Details regarding energy conservation

• Steps taken on Conservation of Energy and impact thereof: Conservation of energy is an ongoing process in the Company. Every effort is made
towards optimum utilization of energy. Efforts are also directed towards eliminating wastage in all areas of operations. • Steps taken by the
company for utilizing alternate sources of energy: Nil. • Capital investment on energy conservation equipment: There are no substantial additional
investments and proposals for reduction in energy consumption at present. The same will be undertaken as and when necessary by the Company.
Details regarding technology absorption

15.2 TECHNOLOGY ABSORPTION: i) Efforts were made towards technology absorption: Nil ii) benefits derived as a result of the above
efforts, e.g. product improvement, cost reduction, product development, import substitution: Nil iii) In case of imported technology (imported
during the last 3 years reckoned from the beginning of the financial year), following information may be furnished: a) Details of technology
imported - Nil b) Year of import - Nil c) Whether the technology been fully absorbed - Nil d) If not fully absorbed, areas where absorption has not
taken e) place, and the reasons therefore - Nil iv) Expenditure incurred on Research and Development - Nil
Details regarding foreign exchange earnings and outgo

15.3 FOREIGN EXCHANGE EARNINGS & OUTGO: During the year under review, the Company has the following Foreign Exchange
Earnings & Outgo: (Amount in Rs) S. No. Particulars As on 31st March, 2016 As on 31st March, 2015 1. Foreign Exchange Earnings Nil Nil 2.
Foreign Exchange Outgo Nil Nil
Disclosures in director’s responsibility statement

11 DIRECTOR’S RESPONSIBILITY STATEMENT: Pursuant to Section134 (5) of the Companies Act, 2013, the Directors confirm that: (i) In
the preparation of the annual accounts for the year ended 31st March, 2016 the applicable accounting standards had been followed along with
proper explanation relating to material departures; (ii) the directors had selected such accounting policies and applied them consistently and made
judgments and estimates that are reasonable and prudent so as to give a true and fair view of the state of affairs of the company at the end of the
financial year 31st March, 2016 and of the profits of the company for that period; (iii) the directors had taken proper and sufficient care for the
maintenance of adequate accounting records in accordance with the provisions of this Act for safeguarding the assets of the company and for
preventing and detecting fraud and other irregularities; (iv) the directors had prepared the annual accounts for the period ended 31st March, 2016
on a going concern basis. (v) that the directors have laid down internal controls to be followed by the Company and that such internal financial
controls are adequate and were operating effectively; (vi) the directors had devised proper systems to ensure compliance with the provisions of all
applicable laws and that such systems were adequate and operating effectively.
27
Particulars of loans guarantee investment under section 186 [Text Block]

Particulars relating to loan or guarantee to any person or body corporate made by the Company during the Financial Year pursuant to Section 186
of Companies Act, 2013 is as follows:
Investment in Equity shares of its Subsidiaries
In Rs Millions
1. Optival Health Solutions Private Limited 1,415.27 1,185.27
2. Ritemed Pharma Retail Private Limited 230.00 230.00
3. MHS Pharmaceuticals Private Limited 0.10 0.10
4. PanIndia Pharma Distributors Private Limited 43.60 26.60
5. Ritecure Pharma Private Limited 0.10 0.10
6. Medsupply Distributors Private Limited 125.77 125.77
7. Sai Sridhar Pharma Private Limited (through its Subsidiary) 0.24 0.24
8. Venkata Krishna Enterprises Private Limited (through its Subsidiary) 0.18 0.18
9. Shri Banashankari Pharma Private Limited (through its Subsidiary) 2.10 2.10
10. Deccan Medisales Private Limited (through its Subsidiary) 2.10 2.10
11. Sidson Pharma Distributors Private Limited (through its Subsidiary) 20.10 Nil
28
Loans given
The Company has not given any loans during this financial year.
Corporate Guarantee given
(Rs. In Millions)
1. Ritemed Pharma Retail Private Limited - 180.00
2. Optival Health Solutions Private Limited - 750.00
29
Particulars of contracts/arrangements with related parties under section 188(1) [Text Block]
Form No. AOC-2
(Pursuant to clause (h) of sub-section (3) of section 134 of the Act and Rule 8(2) of the Companies
(Accounts) Rules, 2014)
Form for disclosure of particulars of con tracts/arrangements entered into by the company with related parties referred to in sub-section (1) of
section 188 of the Companies Act, 2013 including certain arms length transactions under third proviso thereto
1. Details of contracts or arrangements or transactions not at arm’s length basis
Date on
which the
special
resolution
Justification
Salient terms of was
Name(s) of Duration of for entering Date(s)
the contracts or Amount passed in
the related Nature of contracts the contracts into such of
arrangements paid as general
SN party and /arrangements/trans / contracts or approval
or transactions advances, meeting
nature of actions arrangements arrangements by the
including the if any as
relationship / transactions or Board
value, if any required
transactions
under first
proviso to
Section
188
Nil
2. Details of material contracts or arrangement or transactions at arm’s length basis
Name(s) of the Nature of Duration of the Salient terms of the contracts Date(s) of Amount
related party and contracts / contracts / or arrangements or approval by paid as
SN
nature of arrangements / arrangements / transactions including the the Board, if advances,
relationship transactions transactions value, if any any if any
30
Optival Health
Solutions Private Management
Providing stewardship
1 Limited services Ongoing - Nil
activities.
rendered
Purchase of fixed
2 Ongoing - - Nil
assets
Purchase of
3 Ongoing - - Nil
Stationery
Pathlogical
4 Testing Services Ongoing - - Nil
rendered
Ritemed Pharma
Retail Private Management
Providing stewardship activities
5 Limited services Ongoing Nil
-
rendered
Pathlogical
6 Testing Services Ongoing Nil
rendered
MHS Management
7 Pharmaceuticals services Ongoing Providing stewardship activities Nil
Private Limited rendered
31
Disclosure of extract of annual return as provided under section 92(3) [Text Block]
ANNEXURE – I
Form No. MGT-9
EXTRACT OF ANNUAL RETURN
as on the financial year ended on 31st

March, 2015
[Pursuant to section 92(3) of the

Companies Act, 2013 and rule 12(1) of the
Companies (Management and

Administration) Rules, 2014]
I. REGISTRATION AND OTHER

DETAILS:
i. CIN :
Registration date
ii. :
Name of the Company

iii. :
Category/Sub Category of the Company

iv. :
Address of the Registered Office and Contact details

v. :
vi.
Whether Listed Company :
Name, Address and contact details of Registrar and Transfer

vii. :
Agent, if any
II. PRINCIPAL BUSINESS ACTIVITIES OF THE COMPANY:
All the business activities contributing 10%

or more of the total turnover of the
32
Company shall be stated:
NIC Code of the Product/

SI. No. Name and Description of main products / services
service
1. Pathological Laboratories Testing and Hospital and Medical Care 86905
PARTICULARS OF HOLDING, SUBSIDIARY AND ASSOCIATE

III.
COMPANIES:
S. No Name and address of the Company CIN/GLN
Optival Health Solutions Private Limited

Address: H. No: 11-6-56, Survey No: 257 & 258/1, Opp:IDPL
1 U85110TG2005PTC046821
Railway Siding Road,(Moosapet),Kukatpally, Hyderabad,
Telangana - 500037.
Ritemed Pharma Retail Private Limited

2 U52399TG2009PTC064130
Telangana - 500037.
MHS Pharmaceuticals Private Limited

3 U24233TG2008PTC059624
Telangana - 500037.
PanIndia Pharma Distributors Private Limited

4 Address: D. No.8-3-166/1/A, Ground and First Floor, Erragadda, U24232TG2007PTC055895
Telangana - 500018.
Ritecure Pharma Private Limited

5 U24232TG2008PTC058385
Telangana - 500037.
Medsupply Distributors Private Limited

Address: Ground Floor,12-7-20/64/2, Survey No. 793, Goods
6 U24239TG2007PTC052676
Shed Road, Moosapet, Kukatpally, Hyderabad, Telangana -
500018.
Sai Sridhar Pharma Private Limited

7 Address: D. No.8-3-166/1/A, Ground and First Floor, Erragadda, U24232TG2007PTC055902
Telangana – 500 018.
Venkata Krishna Enterprises Private Limited

8 Address: H. No.1-1-650/17, Gandhi Nagar, New Bakaram, U51909TG2010PTC071012
Hyderabad – 500 080.
Deccan Medisales Private Limited

Address: M. No: 562/105/1, Portion I, 1st Main Road, S R
9 U51397KA2011PTC059204
Compound, South City Road, Bannerughatta Road,
Bangalore,560076.
Shri Banashankari Pharma Private Limited

Address: M. No: 562/105/1, Portion II, 1st Main Road, S R
10 U74900KA2014PTC074302
Compound, South City Road, Bannerughatta Road,
Bangalore,560076.
Sidson Pharma Distributors Private Limited

11 Address: Plot No:5,First Floor,Opp:IDPL Company Balanagar U74900TG2014PTC092145
Hyderabad, 500037.
33
SHARE HOLDING PATTERN (Equity Share Capital Breakup as

IV.
percentage of Total Equity)
i) Category-wise Share Holding
No. of Shares held at the

Category of Shareholders No. of Shares held at the beginning of the year
end of the year
Demat Physical Total
A.Promoters
(1) Indian
a) Individual/HUF 21945 11,335
b) Central Govt. 0 0
c) State Govt. 0 0
d)Bodies Corporate 0 0
e)Bank/FI's 0 0
f) Any Other 0 0
Sub-Total (A)(1):- 21,945 11,335
(2) Foreign
a) NRI's-Individuals 0 0
b) Other Individuals 0 0
c)Bodies Corporate 0 0
d)Bank/FI's 0 0
e) Any Other 0 0
Sub-Total (A)(2):- 0 0
Total Shareholding of Promoter (A)=

(A)(1)+(A)(2)
21,945 11,335 33,280
B) Public Shareholding
1. Institutions
a) Mutual Funds 0
b) Banks/FI's 0
c) Central Govt. 0
d) State Govt. 0
e) Ventrure Capital Funds 0
f) Insurance Companies 0
34
g) FII's 0
h) Foreiegn Venture Capital 0
i)Others (Specify) 0
Sub-Total (B)(1):- 0
2. Non-Institutions
a) Bodies Corporate
i) Indian 18834
ii) Overseas 87340
b) Individuals 1132
i) Individual Shareholders holding nominal

0 15,496
share capital in upto Rs. 1 Lakh
ii) Individual Shareholders holding nominal

0 0
share capital in excess of Rs. 1 Lakh
c) Others (specify) 0 4599
Sub-Total (B)(2):- 107,306 37,320
Total Public Shareholding

107,306 37,320
(B)=(B)(1)+(B)(2)
C. Shares held by Custodians for ADR's &

0 0
GDR's
Grand Total
129,251 48,655
(A+B+C)
ii) Shareholding of Promoters
Shareholding
Shareholding
Shareholder's at the
S.No. at the end of
Name beginning of
the year
the year
% of Shares % of Shares
% of total
% of total Shares of Pledged / No. of Pledged /
No. of Shares Shares of the
the company encumbered Shares encumbered
company
to total to total
G. Madhukar
1 33,280 18.71 0.00 33,280
Reddy
2 C. Bhaskar Reddy 0 0.00 0.00 0
Total 33,280 18.71 0.00 33,280
(iii) Change in Promoters' Shareholding (

please specify, if there is no change)
Shareholding Cumulative
at the Shareholding
35
S.No. beginning of during the

the year year
% of Total % of Total
No. of Shares of No. of Shares of
Shares the Shares the
Company Company
At the beginning of NO
1
the year CHANGE
Date wise Increase

/ Decrease in
Promoters
Shareholding
2
during the year
(specifying the
reasons for
increase/decrease
At the end of the

3
year
Total
(iv) Shareholding Pattern of top ten

Shareholders (other than Directors, Promoters
and Holders of GDRs and ADRs):
Shareholder's at the Shareholding
S.No.
Name beginning of during the
the year year
MKCP Direct
1 Investments
(Mauritius) IV Ltd
Company Company
At the beginning of
87340 49.09 87340 49.09
the year
Date wise Increase

/ Decrease in
Promoters
Shareholding
- - - -
during the year
(specifying the
reasons for
increase/decrease
At the end of the

- - 87340 49.09
year
Total 87340 49.09

S.No.
the year year
IL & FS Trust
Company Limited
36
2 (As trustee of TVS No. of Shares of No. of Shares of

Sriram Growth Shares the Shares the
Fund I) Company Company
At the beginning of
18834 10.59 18834 10.59
the year
Date wise Increase

/ Decrease in
Promoters
Shareholding
- - - -
during the year
(specifying the
reasons for
increase/decrease
At the end of the

- - 18834 10.59
year
Total 18834 10.59

S.No.
the year year
IL & FS Trust
Company Limited
3 (As trustee of India
Venture Trust -
Company Company
Fund-1)
At the beginning of
16173 9.09 16173 9.09
the year
Date wise Increase

/ Decrease in
Promoters
Shareholding
- - - -
during the year
(specifying the
reasons for
increase/decrease
At the end of the

- - 16173 9.09
year
Total 16173 9.09

S.No.
the year year
G.Madhukar Reddy
( As trustee of
4 MedPlus
Employees Benefit
Company Company
Fund)
37
At the beginning of
9673 5.44 9673 5.44
the year
Date wise Increase

/ Decrease in
Promoters
Shareholding
- - - -
during the year
(specifying the
reasons for
increase/decrease
At the end of the

- - 9673 5.44
year
Total 9673 5.44

S.No.
the year year
Varalakshmi No. of Shares of No. of Shares of
5
Koppolu Shares the Shares the
Company Company
At the beginning of
5823 3.27 5823 3.27
the year
Date wise Increase

/ Decrease in
Promoters
Shareholding
- - - -
during the year
(specifying the
reasons for
increase/decrease
At the end of the

- - 5823 3.27
year
Total 5823 3.27

S.No.
the year year
Regal Corporate No. of Shares of No. of Shares of
6
Advisors Pvt Ltd Shares the Shares the
Company Company
At the beginning of
714 0.40 714 0.40
the year
Date wise Increase
38
/ Decrease in
Promoters
Shareholding - - - -
during the year
(specifying the
reasons for
increase/decrease
At the end of the

- - 714 0.40
year
Total 714 0.40

S.No.
the year year
Vivek Mundra ( No. of Shares of No. of Shares of
7
HUF) Shares the Shares the
Company Company
At the beginning of
714 0.40 714 0.40
the year
Date wise Increase

/ Decrease in
Promoters
Shareholding
- - - -
during the year
(specifying the
reasons for
increase/decrease
At the end of the

- - 714 0.40
year
Total 714 0.40

S.No.
the year year
8 Sridhar Kotagiri
Company Company
At the beginning of
593 0.33 593 0.33
the year
Date wise Increase

/ Decrease in
Promoters
Shareholding
during the year - - - -
39
(specifying the
reasons for
increase/decrease
At the end of the

- - 593 0.33
year
Total 593 0.33

S.No.
the year year
9 N.Lakshminarayana
Company Company
At the beginning of
539 0.30 539 0.30
the year
Date wise Increase

/ Decrease in
Promoters
Shareholding
- - - -
during the year
(specifying the
reasons for
increase/decrease
At the end of the

- - 539 0.30
year
Total 539 0.30

S.No.
the year year
10 J.Kondal Rayudu
Company Company
At the beginning of
420 0.24 420 0.24
the year
Date wise Increase

/ Decrease in
Promoters
Shareholding
- - - -
during the year
(specifying the
reasons for
increase/decrease
At the end of the
40
year - - 420 0.24
Total 420 0.24

S.No.
the year year
11 Tera Padmamma
Company Company
At the beginning of
420 0.24 420 0.24
the year
Date wise Increase

/ Decrease in
Promoters
Shareholding
- - - -
during the year
(specifying the
reasons for
increase/decrease
At the end of the

- - 420 0.24
year
Total 420 0.24

S.No.
the year year
12 Ajay Kumar Bannai
Company Company
At the beginning of
359 0.20 359 0.20
the year
Date wise Increase

/ Decrease in
Promoters
Shareholding
- - - -
during the year
(specifying the
reasons for
increase/decrease
At the end of the

- - 359 0.20
year
Total 359 0.20
41
(v) Shareholding of Directors and Key

Managerial Personnel:
S.No.
the year year
G. Madhukar No. of Shares of No. of Shares of
1
Reddy Shares the Shares the
Company Company
At the beginning of
33280 18.71 33280 18.71
the year
Date wise Increase

/ Decrease in
Promoters
Shareholding
- - - -
during the year
(specifying the
reasons for
increase/decrease
At the end of the

3 - - 33280 18.71
year

S.No.
the year year
2 C. Bhaskar Reddy
Company Company
At the beginning of
0 0.00 0 0.00
the year
Date wise Increase

/ Decrease in
Promoters
Shareholding
- - - -
during the year
(specifying the
reasons for
increase/decrease
At the end of the

3 - - 0 0.00
year

S.No.
the year year
Roy Edwin No. of Shares of No. of Shares of
3 the the
Campbell II Shares Shares
42
Company Company
At the beginning of
- - - -
the year
Date wise Increase

/ Decrease in
Promoters
Shareholding
- - - -
during the year
(specifying the
reasons for
increase/decrease
At the end of the

3 - - - -
year

S.No.
the year year
4 Sudha Ravi
Company Company
At the beginning of
- - - -
the year
Date wise Increase

/ Decrease in
Promoters
Shareholding
- - - -
during the year
(specifying the
reasons for
increase/decrease
At the end of the

3 - - - -
year

S.No.
the year year
5 Atul Kumar Agarwal
Company Company
At the beginning of
- - - -
the year
Date wise Increase

/ Decrease in
Promoters
Shareholding
during the year - - - -
43
(specifying the
reasons for
increase/decrease
At the end of the

3 - - - -
year

S.No.
the year year
6 Parag Kumar Jain
Company Company
At the beginning of
- - - -
the year
Date wise Increase

/ Decrease in
Promoters
Shareholding
- - - -
during the year
(specifying the
reasons for
increase/decrease
At the end of the

3 - - - -
year
V. INDEBTNESS
Indebtedness of the Company including

interest outstanding/accrued but not due for
payment
Secured Loans Unsecured Total

Deposits
excluding deposits Loans (NCD) Indebtedness
Indebtedness at the beginning of the financial

year
i) Principal Amount 0 0 0 0
ii) Interest due but not paid 0 0 0 0
iii) Interest accrued but not due 0 0 0 0
Total (i+ii+iii)
Changes in Indebtedness during the year
Addition 0 430,270,000 0 430,270,000
Reduction 0 0 0 0
Net Change 0 430,270,000 0 430,270,000
Indebtedness at the end of the financial year
i) Principal Amount 0 430,270,000 0 430,270,000
44
ii) Interest due but not paid 0 0 0 0
iii) Interest accrued but not due 0 0 0 0
Total (i+ii+iii) 0 430,270,000 0 430,270,000
VI. REMUNERATION TO DIRECTORS AND

KEY MANAGERIAL PERSONNEL:
A. Remuneration to Managing Director,

Whole-Time Director and/or Manager:
Particulars of Name of Total

S.No.
Remuneration Director Amount
G. Madhukar Reddy
1 Gross salary 4000000 4000000
(a) Salary as per

provisions
contained in section
17(1) of the
Income-tax Act,
1961
(b) Value of
perquisites u/s
17(2) Income-tax
Act, 1961
(c) Profits in lieu of

salary under
section 17(3)
Income-tax Act,
1961
2 Stock Option
Sweat Equity
3
Shares
4 Commission
- as %
-others
5 Others
Total (A) 4000000 4000000
Ceiling as per the

N/A N/A N/A
Act
B. Remuneration to other Directors:
Particulars of Name of Total

S.No.
Remuneration Director Amount
C. Bhaskar
Reddy
Independent
1 - -
Directors
•Fee for attending
45
Board Committee - -
Meetings
•Commission - -
•Others - -
Total (1) - -
Other
2 Non-Executive - -
Directors
•Fee for attending

Board Committee - -
Meetings
•Commission - -
•Others 5,336,100 5336100
Total (2) -
Total (B)(1)+(2) -
Total Managerial
Remuneration (A + 5,336,100 5336100
B)
Overall Ceiling as
N/A
per the Act
C. Remuneration to Key Managerial

Personnel Other than MD/MANAGER/WTD
Name of Key
Particulars of Total
S.No. Managerial
Remuneration Amount
Person
Mr. Atul Kumar

Mr. Parag Jain [CS]
Agarwal [CFO]
1 Gross salary 762277 5082000 5844277
(a) Salary as per

provisions
contained in section
17(1) of the
Income-tax Act,
1961
(b) Value of
perquisites u/s
17(2) Income-tax
Act, 1961
(c) Profits in lieu of

salary under
section 17(3)
Income-tax Act,
1961
2 Stock Option
Sweat Equity
3
Shares
4 Commission
46
- as %
-others
5 Others
Total 762277 5082000 5844277
VII.
PENALITIES/PUNISHMENT/COMPOUNDING
OF OFFENCES: Nil
Section of The Brief Details of Appeals

Type
Companies Act Description Authority Made
Penalty/Punishment/ Compounding of Fees

[RD/NCLT/Court]
Imposed
A. COMPANY
Penalty - - - - -
Punishment - - - -
Compounding - - - -
B. DIRECTORS
Penalty - - - - -
Punishment - - - - -
Compounding - - - - -
C. OTHER OFFICERS IN DEFAULT
Penalty - - - - -
Punishment - - - - -
Compounding - - - - -
G. Madhukar C. Bhaskar
Reddy Reddy
Managing
Director
Director
DIN: DIN:
00098097 00926550
Disclosure of statement on declaration given by independent directors under section 149(6) [Text Block]
Since the Company is a Listed Private Company, appointment of Independent directors as per sub section (4) of section 149 of the Companies
Act, 2013, is not mandatory to your Company.
47
Disclosure for companies covered under section 178(1) on directors appointment and remuneration including other
matters provided under section 178(3) [Text Block]
The general terms of appointment of Directors, KMP and Senior Managerial personnel is provided hereunder:
F They are identified and ascertained based on the integrity, qualification, expertise and experience for appointment as Director, KMP or at Senior
Management level and the Board decides whether qualification, expertise and experience possessed by a person are sufficient / satisfactory for the
concerned position
Disclosure of statement on development and implementation of risk management policy [Text Block]
1 RISK MANAGEMENT:
As a diversified enterprise, your Company continues to focus on a system-based approach to business risk management. The management of risk
is embedded in the corporate strategies of developing a portfolio of world-class businesses that best match organizational capability with market
opportunities, focusing on building distributed leadership and succession planning processes, nurturing specialism and enhancing organisational
capabilities through timely developmental inputs.
The Company has initiated procedure for risk assessment and its minimization.
48
Disclosure of financial summary or highlights [Text Block]

1. STATEMENT OF AFFAIRS:
The Company’s financial performance for the financial year ended as on 31st March, 2016 is summarized below:
Amount (In Rs)
Total Expenses 75,536,193 70,213,893
Profit/Loss before Tax (43,035,759) (52,019,410)
Profit/Loss after Tax (43,035,759) (52,019,410)
Balance carried to Balance sheet (43,035,759) (52,019,410)
49
Details of directors or key managerial personnels who were appointed or have resigned during year [Text Block]
Following are the Directors and Key Managerial Personnel of the Company as on date:
S. No. Name of Director Designation
1. Mr. G. Madhukar Reddy Managing Director
2. Mr. Cherukupalli Bhaskar Reddy Director
3. Mr. Roy Edwin Campbell II Nominee Director
4. Ms. Sudha Ravi Nominee Director
5. Mr. Atul Kumar Agarwal Chief Financial Officer
6. Mr. Parag Kumar Jain Company Secretary
Appointment :
Following are the particulars of appointments and re-appointments of the Directors and Key Managerial Personnel of your Company during the
Financial Year 2015-16:
Mr. Atul Kumar Agarwal was appointed as Chief Financial Officer of the Company on 28th January, 2016.
50
Details relating to deposits covered under chapter v of companies act [Text Block]
The Company doesn’t have any deposits as covered under chapter V of the Companies Act, 2013, following are the disclosures:
· Deposits accepted during the year : Nil
· remained unpaid or unclaimed as at the end of the year : Nil
· whether there has been any default in repayment of deposits or payment of interest thereon during the year and if so, number of such cases
and the total amount involved -
(i) at the beginning of the year; Nil
(ii) maximum during the year; Nil
(iii) at the end of the year; Nil
Details regarding adequacy of internal financial controls with reference to financial statements [Text Block]
Your Company has effective ‘internal financial controls’ that ensure an orderly and efficient conduct of its business, including adherence to
company’s policies, safeguarding of its assets, prevention and detection of frauds and errors, accuracy and completeness of the accounting
records, and timely preparation of reliable financial information.
While these controls have been effective through-out the year, these are reviewed on a periodic basis for any changes/ modifications to align to
business needs.
51
Disclosure of appointment and remuneration of managerial personnels [Text Block]

The Company’s Remuneration Strategy is designed to attract and retain quality talent that gives its business a competitive advantage and enables
the Company to achieve its objectives. The Company’s Remuneration Strategy, whilst focusing on remuneration and related aspects of
performance management, is aligned with and reinforces the employee value proposition of a superior quality of work life, that includes an
enabling work environment, an empowering and engaging work culture and opportunities to learn and grow. The Compensation approach
endeavours to align each employee with the Company’s goals.
v Remuneration to Key Managerial Personnel (“KMP”):
a) Remuneration of KMP is determined, recommended by the Remuneration Committee and is approved by the Board. Remuneration of the
Managing Director / Whole time Director is also subject to the approval of the shareholders.
b) Remuneration is reviewed and revised periodically, when such a revision is warranted by the market.
c) Apart from fixed elements of remuneration and benefits, the KMP are also eligible for Variable Pay / Performance Bonus which is linked
to their individual performance and the overall performance of the Company.
v Remuneration of employees other than KMP:
a) Remuneration of employees other than KMP is approved by the Board.
Remuneration is reviewed and revised periodically, when such a revision is warranted by the market. The quantum of revision is linked to market
trends, the competitive context of the Company’s business, as well as the track record of the individual employee.
52
[400200] Disclosures - Auditors report
Disclosure of auditor's qualification(s), reservation(s) or adverse remark(s) in auditors' report [Table] ..(1)
Auditor's
Auditor's qualification(s), reservation(s) or adverse remark(s) in auditors' report [Axis] favourable remark
[Member]
01/04/2015
to
31/03/2016
Disclosure of auditor's qualification(s), reservation(s) or adverse remark(s) in auditors' report [Abstract]
Disclosure of auditor's qualification(s), reservation(s) or adverse remark(s) in auditors' report
[LineItems]
Disclosure in auditors report relating to fixed assets Favourable Remark
The Company has
maintained proper
records showing full
Disclosure relating to quantitative details of fixed assets particulars, including
quantitative details
and situation of fixed
assets.
Textual information
Disclosure relating to physical verification and material discrepancies of fixed assets (17) [See below]
Textual information
Disclosure relating to title deeds of immovable properties (18) [See below]
The management has
conducted physical
verification of
inventory at
reasonable intervals
Disclosure in auditors report relating to inventories during the year and
no material
discrepancies were
noticed on such
physical
Textual information
Disclosure in auditors report relating to loans (19) [See below]
Textual information
Disclosure in auditors report relating to compliance with Section 185 and 186 of Companies Act, 2013 (20) [See below]
The Company has
not accepted any
Disclosure in auditors report relating to deposits accepted deposits from the
public
Textual information
Disclosure in auditors report relating to maintenance of cost records (21) [See below]
Textual information
Disclosure in auditors report relating to statutory dues [TextBlock] (22) [See below]
Textual information
Disclosure in auditors report relating to default in repayment of financial dues (23) [See below]
Disclosure in auditors report relating to public offer and term loans used for purpose for which Textual information
those were raised (24) [See below]
Disclosure in auditors report relating to fraud by the company or on the company by its officers Textual information
or its employees reported during period (25) [See below]
Textual information
Disclosure in auditors report relating to managerial remuneration (26) [See below]
In our opinion, the
Company is not a
nidhi company.
Therefore, the
provisions of clause
Disclosure in auditors report relating to Nidhi Company 3(xii) of the order
are not applicable to
the Company and
hence not
commented upon.
Textual information
Disclosure in auditors report relating to transactions with related parties (27) [See below]
Disclosure in auditors report relating to preferential allotment or private placement of shares or Textual information
convertible debentures (28) [See below]
Disclosure in auditors report relating to non-cash transactions with directors or persons connected Textual information
with him (29) [See below]
53
According to the
information and
explanations given
to us, the provisions
Disclosure in auditors report relating to registration under section 45-IA of Reserve Bank of India
of section 45¬ IA of
Act, 1934 the Reserve Bank of
India Act, 1934 are
not applicable to the
Company.
Details regarding auditors [Table] ..(1)

Auditors [Axis] Column 1
01/04/2015
to
31/03/2016
Details regarding auditors [Abstract]
Details regarding auditors [LineItems]
Category of auditor Auditors firm
S.R.Batliboi & Co.
Name of audit firm LLP
NAVNEETRAI
Name of auditor signing report GOPALRAI
KABRA
Firms registration number of audit firm 101049W
Membership number of auditor 102328
PLOT NO 18 OVAL
OFFICE ILABS
CENTRE
SOFTWARE
Address of auditors UNITS LAYOUT
HITEC CITY
MADHAPUR
HYDERABAD
500081 INDIA
Permanent account number of auditor or auditor's firm ABSFS4151K
SRN of form ADT-1 C26270124
Date of signing audit report by auditors 28/05/2016
Date of signing of balance sheet by auditors 28/05/2016

01/04/2015
to
31/03/2016
Disclosure in auditor’s report explanatory [TextBlock] [See below]
Whether companies auditors report order is applicable on company Yes
Whether auditors' report has been qualified or has any reservations or
No
contains adverse remarks
Disclosure relating to physical verification and material discrepancies of fixed assets

All fixed assets have not been physically verified by the management during the year but there is a regular programme of verification which, in
our opinion, is reasonable having regard to the size of the Company and the nature of its assets. No material discrepancies were noticed on such
verification.
Disclosure relating to title deeds of immovable properties

According to the information and explanations given by the management, there are no immovable properties, included in fixed assets of the
Company and accordingly, the requirements under paragraph 3(i)(c) of the Order are not applicable to the Company.
54
Disclosure in auditors report relating to loans

According to the information and explanations given to us, the Company has not granted any loans, secured or unsecured to companies, firms,
limited liability partnerships or other parties covered in the register maintained under section 189 of the Companies Act, 2013. Accordingly, the
provisions of clause 3(iii) (a), (b) and (c) of the Order are not applicable to the Company and hence not commented upon.
Disclosure in auditors report relating to compliance with Section 185 and 186 of Companies Act, 2013
In our opinion and according to the information and explanations given to us, provisions of section 185 and 186 of the Companies Act, 2013 in
respect of loans to directors including entities in which they are interested and in respect of loans and advances given, investments made and,
guarantees, and securities given have been complied with by the Company.
Disclosure in auditors report relating to maintenance of cost records

To the best of our knowledge and as explained, the Central Government has not specified the maintenance of cost records under clause 148(1) of
the Companies Act, 2013, for the services of the Company.
Disclosure in auditors report relating to statutory dues [Text Block]
(a) The Company is regular in depositing with appropriate authorities undisputed statutory dues including provident
fund, employees’ state insurance, income-tax, sales-tax, service tax, value added tax, cess and other material statutory dues
applicable to it. The provisions relating to duty of custom and duty of excise are not applicable to the Company.
(b) According to the information and explanations given to us, no undisputed amounts payable in respect of provident fund,
employees’ state insurance, income-tax, service tax, sales-tax, value added tax, cess and other material statutory dues were
outstanding, at the year end, for a period of more than six months from the date they became payable. The provisions relating to
duty of custom and duty of excise are not applicable to the Company.
(c) According to the information and explanations given to us, there are no dues of income-tax, sales-tax, service tax,
customs duty, excise duty, value added tax and cess which have not been deposited on account of any dispute.
Disclosure in auditors report relating to default in repayment of financial dues

Based on our audit procedures and according to the information and explanations given by the management, we are of the opinion that the
Company has not defaulted in repayment of dues to debenture holders. The Company did not have any outstanding dues in respect of financial
institution, bank or government during the year.
55
Disclosure in auditors report relating to public offer and term loans used for purpose for which those were raised
In our opinion and according to the information and explanations given to us, the Company has utilized the money raised by way of the term
loans during the previous year for the purposes for which they were raised, except for: Nature of the fund raised Details of default (Reason
/Delay) Amount (Rs.) Subsequently rectified (Yes/No) and details Term loans - raised in the form of non-convertible debentures Funds used for
working capital requirements/ funding of losses of the Company 40,927,527 No Also idle/surplus funds which were not required for immediate
utilization have been gainfully invested in liquid investments payable on demand. The maximum amount of idle/surplus funds invested during the
year was Rs. 300,594,839, of which Rs. 17,342,483 (lying in bank current and deposit accounts) was outstanding at the end of the year.
According to the information and explanations given by the management, the Company has not raised any money by way of initial public offer /
further public offer.
Disclosure in auditors report relating to fraud by the company or on the company by its officers or its employees
reported during period
Based upon the audit procedures performed for the purpose of reporting the true and fair view of the financial statements and according to the
information and explanations given by the management, we report that no fraud by the Company or on the Company by the officers and
employees of the Company has been noticed or reported during the year.
Disclosure in auditors report relating to managerial remuneration

According to the information and explanations given by the management, the provisions of section 197 read with Schedule V of the Act is not
applicable to the company and hence reporting under clause 3(xi) are not applicable and hence not commented upon.
Disclosure in auditors report relating to transactions with related parties

According to the information and explanations given by the management, transactions with the related parties are in compliance with section 177
and 188 of Companies Act, 2013 where applicable and the details have been disclosed in the notes to the financial statements, as required by the
applicable accounting standards.
Disclosure in auditors report relating to preferential allotment or private placement of shares or convertible
debentures
According to the information and explanations given to us and on an overall examination of the balance sheet, the Company has not made any
preferential allotment or private placement of shares or fully or partly convertible debentures during the year under review and hence, reporting
requirements under clause 3(xiv) are not applicable to the company and, not commented upon.
Disclosure in auditors report relating to non-cash transactions with directors or persons connected with him
According to the information and explanations given by the management, the Company has not entered into any non-cash transactions with
directors or persons connected with him as referred to in section 192 of Companies Act, 2013.
56
Disclosure in auditor’s report explanatory [Text Block]
INDEPENDENT AUDITOR’S REPORT
To the Members of MedPlus Health Services Private Limited
Report on the Financial Statements
We have audited the accompanying standalone financial statements of MedPlus Health Services Private Limited (“the
Company”), which comprise the Balance Sheet as at March 31, 2016, the Statement of Profit and Loss and Cash Flow Statement
for the year then ended, and a summary of significant accounting policies and other explanatory information.
Management’s Responsibility for the Financial Statements
The Company’s Board of Directors is responsible for the matters stated in Section 134(5) of the Companies Act, 2013 (“the Act”)
with respect to the preparation of these standalone financial statements that give a true and fair view of the financial position,
financial performance and cash flows of the Company in accordance with accounting principles generally accepted in India,
including the Accounting Standards specified under section 133 of the Act, read with Rule 7 of the Companies (Accounts) Rules,
2014. This responsibility also includes maintenance of adequate accounting records in accordance with the provisions of the Act
for safeguarding of the assets of the Company and for preventing and detecting frauds and other irregularities; selection and
application of appropriate accounting policies; making judgments and estimates that are reasonable and prudent; and the design,
implementation and maintenance of adequate internal financial control that were operating effectively for ensuring the accuracy
and completeness of the accounting records, relevant to the preparation and presentation of the financial statements that give a
true and fair view and are free from material misstatement, whether due to fraud or error.
Auditor’s Responsibility
Our responsibility is to express an opinion on these standalone financial statements based on our audit. We have taken into
account the provisions of the Act, the accounting and auditing standards and matters which are required to be included in the
audit report under the provisions of the Act and the Rules made thereunder. We conducted our audit in accordance with the
57
Standards on Auditing, issued by the Institute of Chartered Accountants of India, as specified under Section 143(10) of the Act.
Those Standards require that we comply with ethical requirements and plan and perform the audit to obtain reasonable
assurance about whether the financial statements are free from material misstatement.
An audit involves performing procedures to obtain audit evidence about the amounts and disclosures in the financial statements.
The procedures selected depend on the auditor’s judgment, including the assessment of the risks of material misstatement of the
financial statements, whether due to fraud or error. In making those risk assessments, the auditor considers internal financial
control relevant to the Company’s preparation of the financial statements that give a true and fair view in order to design audit
procedures that are appropriate in the circumstances. An audit also includes evaluating the appropriateness of accounting
policies used and the reasonableness of the accounting estimates made by the Company’s Directors, as well as evaluating the
overall presentation of the financial statements. We believe that the audit evidence we have obtained is sufficient and appropriate
to provide a basis for our audit opinion on the standalone financial statements.
Opinion
In our opinion and to the best of our information and according to the explanations given to us, the standalone financial
statements give the information required by the Act in the manner so required and give a true and fair view in conformity with the
accounting principles generally accepted in India of the State of affairs of the Company as at March 31, 2016, its loss, and its
cash flows for the year ended on that date.
Report on Other Legal and Regulatory Requirements
1 As required by the Companies (Auditor’s Report) Order, 2015 (“the Order”) issued by the Central Government of
India in terms of sub-section (11) of section 143 of the Act, we give in the Annexure 1 a statement on the matters specified in
paragraphs 3 and 4 of the Order.
2 As required by section 143 (3) of the Act, we report that:
(a) We have sought and obtained all the information and explanations which to the best of our knowledge and belief were
necessary for the purpose of our audit;
(b) In our opinion proper books of account as required by law have been kept by the Company so far as it appears from our
examination of those books;
58
(c) The Balance Sheet, Statement of Profit and Loss and Cash Flow Statement dealt with by this Report are in agreement
with the books of account;
(d) In our opinion, the aforesaid standalone financial statements comply with the Accounting Standards specified under section
133 of the Act, read with Rule 7 of the Companies (Accounts) Rules, 2014;
(e) On the basis of written representations received from the directors as on March 31, 2016, and taken on record by the Board of
Directors, none of the directors is disqualified as on March 31, 2016, from being appointed as a director in terms of section 164
(2) of the Act;
(f) With respect to the adequacy of the internal financial controls over financial reporting of the Company and the operating
effectiveness of such controls, refer to our separate Report in “Annexure 2” to this report;
(g) With respect to the other matters to be included in the Auditor’s Report in accordance with Rule 11 of the Companies (Audit
and Auditors) Rules, 2014, in our opinion and to the best of our information and according to the explanations given to us:
i. The Company has disclosed the impact of pending litigations on its financial position in its financial statements – refer
note 27 to the financial statements;
ii. The Company did not have any long-term contracts including derivative contracts for which there were any material
foreseeable losses; and
iii. There were no amounts which were required to be transferred to the Investor Education and Protection Fund by the
Company.
For S.R. Batliboi & Associates LLP
Chartered Accountants ICAI Firm Registration Number: 101049W/E300004
per Navneet Rai Kabra
59
Partner Membership Number: 102328
Place of Signature: Hyderabad Date: May 28, 2016
Annexure 1 referred to in our report of even date
Re: MedPlus Health Services Private Limited (“the Company”)
Company has maintained proper

(i) (a) The records showing full particulars,
including
quantitative details and situation of fixed

assets.
All fixed assets have not been physically

(b) verified by the management during the
year
but there is a regular programme of

verification which, in our opinion, is
reasonable
having regard to the size of the Company

and the nature of its assets. No material
discrepancies were noticed on such

verification.
According to the information and

(c) explanations given by the management,
there are no
immovable properties, included in fixed

assets of the Company and accordingly,
the
60
requirements under paragraph 3(i)(c) of

the Order are not applicable to the
Company.
conducted physical
(ii) The management has verification of inventory
at reasonable
intervals during the year and no material

discrepancies were noticed on such
physical
verification.
(iii) According to the information and explanations given to us, the Company has not granted any loans, secured or
unsecured to companies, firms, limited liability partnerships or other parties covered in the register maintained under section 189
of the Companies Act, 2013. Accordingly, the provisions of clause 3(iii) (a), (b) and (c) of the Order are not applicable to the
Company and hence not commented upon.
(iv) In our opinion and according to the information and explanations given to us, provisions of section 185 and 186 of the
Companies Act, 2013 in respect of loans to directors including entities in which they are interested and in respect of loans and
advances given, investments made and, guarantees, and securities given have been complied with by the Company.
(v ) The Company has not accepted any deposits from the public.
(vi) To the best of our knowledge and as explained, the Central Government has not specified the maintenance of cost
records under clause 148(1) of the Companies Act, 2013, for the services of the Company.
(vii) (a) The Company is regular in depositing with appropriate authorities undisputed statutory dues including provident fund,
employees’ state insurance, income-tax, sales-tax, service tax, value added tax, cess and other material statutory dues
applicable to it. The provisions relating to duty of custom and duty of excise are not applicable to the Company.
(b) According to the information and explanations given to us, no undisputed amounts payable in respect of provident fund,
employees’ state insurance, income-tax, service tax, sales-tax, value added tax, cess and other material statutory dues were
61
outstanding, at the year end, for a period of more than six months from the date they became payable. The provisions relating to
duty of custom and duty of excise are not applicable to the Company.
(c) According to the information and explanations given to us, there are no dues of income-tax, sales-tax, service tax,
customs duty, excise duty, value added tax and cess which have not been deposited on account of any dispute.
(viii) Based on our audit procedures and according to the information and explanations given by the management, we are of
the opinion that the Company has not defaulted in repayment of dues to debenture holders. The Company did not have any
outstanding dues in respect of financial institution, bank or government during the year.
(ix) In our opinion and according to the information and explanations given to us, the Company has utilized the money raised
by way of the term loans during the previous year for the purposes for which they were raised, except for:
Subsequently
Amount
Nature of the fund raised Details of default (Reason /Delay) rectified (Yes/No) and
(Rs.)
details
Term loans - raised in the form of Funds used for working capital requirements/
40,927,527 No
non-convertible debentures funding of losses of the Company
Also idle/surplus funds which were not required for immediate utilization have been gainfully invested in liquid investments
payable on demand. The maximum amount of idle/surplus funds invested during the year was Rs. 300,594,839, of which Rs.
17,342,483 (lying in bank current and deposit accounts) was outstanding at the end of the year. According to the information and
explanations given by the management, the Company has not raised any money by way of initial public offer / further public offer.
(x) Based upon the audit procedures performed for the purpose of reporting the true and fair view of the financial
statements and according to the information and explanations given by the management, we report that no fraud by the Company
or on the Company by the officers and employees of the Company has been noticed or reported during the year.
(xi) According to the information and explanations given by the management, the provisions of section 197 read with
Schedule V of the Act is not applicable to the company and hence reporting under clause 3(xi) are not applicable and hence not
commented upon.
62
(xii) In our opinion, the Company is not a nidhi company. Therefore, the provisions of clause 3(xii) of the order are not
applicable to the Company and hence not commented upon.
(xiii) According to the information and explanations given by the management, transactions with the related parties are in
compliance with section 177 and 188 of Companies Act, 2013 where applicable and the details have been disclosed in the notes
to the financial statements, as required by the applicable accounting standards.
(xiv) According to the information and explanations given to us and on an overall examination of the balance sheet, the
Company has not made any preferential allotment or private placement of shares or fully or partly convertible debentures during
the year under review and hence, reporting requirements under clause 3(xiv) are not applicable to the company and, not
commented upon.
(xv) According to the information and explanations given by the management, the Company has not entered into any
non-cash transactions with directors or persons connected with him as referred to in section 192 of Companies Act, 2013.
(xvi) According to the information and explanations given to us, the provisions of section 45
IA of the Reserve Bank of India Act, 1934 are not applicable to the Company.
For S.R. BATLIBOI & ASSOCIATES LLP
Chartered Accountants ICAI Firm Registration Number: 101049W/E300004
63
per Navneet Rai Kabra
Partner Membership Number: 102328
Place: Hyderabad Date: May 28, 2016
[400500] Disclosures - Secretarial audit report
Details of signatories of secretarial audit report [Table] ..(1)

Signatories of secretarial audit report [Axis] Column 1
01/04/2015
to
31/03/2016
Details of signatories of secretarial audit report [Abstract]
Details of signatories of secretarial audit report [LineItems]
Secretarial auditors
Category of secretarial auditor firm
Name of secretarial audit firm R & A Associates
RAGHU BABU
Name of secretarial auditor signing report GUNTURU
Certificate of practice number of secretarial auditor 2820
Flat # 101, Sapthagi
r i Residency,
1-10-98/A, Chikoti
Address of secretarial auditors Gardens, Begumpet,
Hyderabad,
Telangana-500016
Permanent account number of secretarial auditor or secretarial auditors firm AADFR7405F
Date of signing secretarial audit report 06/09/2016

01/04/2015
to
31/03/2016
Disclosure in secretarial audit report explanatory [TextBlock] [See below]
Whether secretarial audit report is applicable on company Yes
Whether secretarial audit report has been qualified or has any
No
observation or other remarks
64
Disclosure in secretarial audit report explanatory [Text Block]
FORM NO. MR-3
SECRETARIAL AUDIT REPORT
FOR THE FINANCIAL YEAR ENDED MARCH 31, 2016
[Pursuant to section 204(1) of the Companies Act, 2013 and rule no.9 of the Companies (Appointment and Remuneration of Managerial
Personnel) Rules, 2014]
To
The Members
M/s. MedPlus Health Services Private Limited
707, 7th Floor, 5-9-13,
Taramandal Commercial Complex, Saifabad,
Hyderabad, Telangana – 500 004.
We have conducted the secretarial audit of the compliance of applicable statutory provisions and the adherence to good corporate practices by
M/s. MedPlus Health Services Private Limited (hereinafter called the “Company”). Secretarial Audit was conducted in a manner that provided us
a reasonable basis for evaluating the corporate conducts/statutory compliances and expressing our opinion thereon.
Based on our verification of the Company’s books, papers, minute books, forms and returns filed and other records maintained by the Company
and also the information provided by the Company, its officers, agents and authorized representatives during the conduct of secretarial audit, we
hereby report that in our opinion, the Company has, during the audit period covering the financial year ended on March 31, 2016 complied with
the statutory provisions listed hereunder and also that the Company has proper board-processes and compliance-mechanism in place to the extent,
in the manner and subject to the reporting made hereinafter.
65
We have examined the books, papers, minute books, forms and returns filed and other records maintained by the Company for the financial year
ended on March 31, 2016 according to the provisions of:
i. The Companies Act, 2013 (the Act) and the rules made thereunder;
ii. The Securities Contracts (Regulation) Act, 1956 (‘SCRA’) and the rules made thereunder; (Not applicable to the Company during
the Audit Period);
iii. The Depositories Act, 1996 and the Regulations and Bye-laws framed thereunder;
iv. Foreign Exchange Management Act, 1999 and the rules and regulations made thereunder to the extent of Foreign Direct Investment;
v. The Securities Exchange Board of India (Issue and Listing of Debt Securities), Regulations, 2008/ The Securities Exchange Board of
India (Listing Obligation and Disclosure Requirements) Regulations, 2015 ;
vi. Other Regulations and Guidelines prescribed under the Securities and Exchange Board of India Act, 1992 (‘SEBI Act’): (Not
applicable to the Company during the Audit Period).
We have also examined compliance with the applicable clauses of the following:
i. Secretarial Standards issued by The Institute of Company Secretaries of India
ii. The Debt Listing Agreement entered into by the Company with BSE Limited.
During the period under review, the Company has complied with the provisions of the Act, Rules, Regulations, Guidelines, Standards, etc.,
mentioned above.
We further report that the Board of Directors of the Company is duly constituted with proper balance of Executive Directors and Non-Executive
Directors. The changes in the composition of the Board of Directors that took place during the period under review were carried out in
compliance with the provisions of the Act.
Adequate notice was given to all Directors at least seven days in advance to schedule the Board Meetings. Agenda and detailed notes on agenda
were sent in advance, and a system exists for seeking and obtaining further information and clarifications on the agenda items before the meeting
and for meaningful participation at the meeting. Consent of directors was obtained for the board meetings called with shorter notices.
66
All decisions at Board Meetings are carried out unanimously as recorded in the minutes of the meetings of the Board of Directors or Committee
of the Board, as the case may be.
We further report that the Company is engaged in the business of pathological laboratory testing and the following laws are applicable
specifically to the Company:
(a) Andhra Pradesh Private Medical Care Establishments (Registration & Regulation) Act, 2002.
(b) Bio-Medical Waste (Management and Handling) Rules, 1998.
During the period under review, the Company has complied with the provisions of the Act and Rules mentioned above.
We further report that there are adequate systems and processes in the Company commensurate with the size and operations of the Company to
monitor and ensure compliance with applicable laws, rules, regulations and guidelines.
We further report that during the audit period there were no other specific events/actions having a major bearing on the Company’s affairs in
pursuance of the above referred laws, rules, guidelines and standards except the above referred events.
For R & A Associates
(G. Raghu Babu)
Partner
Date : 6th September, 2016 FCS No.: 4448
Place : Hyderabad C P No.: 2820
This report is to be read with our letter of even date, which is annexed as “Annexure – A” attached herewith and forms an integral part of this
report.
67
“Annexure – A”
To
The Members
M/s. MedPlus Health Services Private Limited
707, 7th Floor, 5-9-13,
Taramandal Commercial Complex, Saifabad.
Hyderabad, Telangana – 500 004.
Our report of even date is to be read along with this letter:
1. Maintenance of secretarial records is the responsibility of the management of M/s. MedPlus Health Services Private Limited (“the
Company”). Our responsibility is to express an opinion on these secretarial records based on our audit.
2. We have followed the audit practices and processes as were appropriate to obtain reasonable assurance about the correctness of the contents
of the Secretarial records. The verification was done on the random test basis to ensure that correct facts are reflected in secretarial records. We
believe that the processes and practices, we followed provide a reasonable basis for our opinion.
3. We have not verified the correctness and appropriateness of financial records and Books of Accounts of the Company.
4. The compliance of the provisions of Corporate and other applicable laws, rules, regulations, standards is the responsibility of management.
Our examination was limited to the verification of procedures on random test basis.
5. The Secretarial Audit report is neither an assurance as to the future viability of the Company nor of the efficacy or effectiveness with which
the management has conducted the affairs of the Company.
For R & A Associates
(G. Raghu Babu)
Partner
Date : 6th September, 2016 FCS No.: 4448
68
Place : Hyderabad C P No.: 2820
[100100] Balance sheet

31/03/2016 31/03/2015 31/03/2014
Balance sheet [Abstract]
Equity and liabilities [Abstract]
Shareholders' funds [Abstract]
Share capital 12,40,13,510 12,40,13,510 17,79,060
Reserves and surplus 108,24,85,425 125,79,41,813
Total shareholders' funds 120,64,98,935 138,19,55,323
Share application money pending allotment 0 0
Non-current liabilities [Abstract]
Long-term borrowings 43,02,70,000 43,02,70,000
Other long-term liabilities 19,79,26,906 5,24,44,825
Long-term provisions 4,06,601 9,52,862
Total non-current liabilities 62,86,03,507 48,36,67,687
Current liabilities [Abstract]
Short-term borrowings 0 0
Trade payables (A) 67,66,653 (B) 60,13,546

Other current liabilities 10,67,453 11,57,495
Short-term provisions 23,70,381 21,38,373
Total current liabilities 1,02,04,487 93,09,414
Total equity and liabilities 184,53,06,929 187,49,32,424
Assets [Abstract]
Non-current assets [Abstract]
Fixed assets [Abstract]
Tangible assets 72,93,487 86,14,634 1,19,29,014
Intangible assets 0 0
Total fixed assets 72,93,487 86,14,634
Non-current investments 177,31,51,280 152,61,51,290
Long-term loans and advances 4,15,00,339 3,50,43,303
Other non-current assets 75,000 75,000
Total non-current assets 182,20,20,106 156,98,84,227
Current assets [Abstract]
Current investments 0 0
Inventories 13,01,792 9,93,670
Trade receivables 17,96,940 20,55,578
Cash and bank balances 1,74,52,153 30,07,59,063
Short-term loans and advances 26,23,886 6,88,281
Other current assets 1,12,052 5,51,605
Total current assets 2,32,86,823 30,50,48,197
Total assets 184,53,06,929 187,49,32,424
Footnotes
(A) Trade payables ?? -Total outstanding dues of micro enterprises and small enterprisesRs.0.00 ?? -Total outstanding dues of creditors
other than micro enterprises . and small enterprises Rs.6766653
(B) Trade payables ?? -Total outstanding dues of micro enterprises and small enterprisesRs.0.00 ?? -Total outstanding dues of creditors
other than micro enterprises . and small enterprises Rs.6013546
69
[400300] Disclosures - Signatories of financial statements
Details of directors signing financial statements [Table] ..(1)

Directors signing financial statements [Axis] Column 1 Column 2
01/04/2015 01/04/2015
to to
31/03/2016 31/03/2016
Details of signatories of financial statements [Abstract]
Details of directors signing financial statements [Abstract]
Details of directors signing financial statements [LineItems]
Name of director signing financial statements [Abstract]
First name of director GANGADI CHERUKUPALLI
Middle name of director MADHUKAR BHASKAR
Last name of director REDDY REDDY
Designation of director Managing Director Director
Director identification number of director 00098097 00926550
Date of signing of financial statements by director 28/05/2016 28/05/2016
70
[100400] Cash flow statement, indirect

01/04/2015 01/04/2014
to to 31/03/2014
31/03/2016 31/03/2015
Statement of cash flows [Abstract]
Whether cash flow statement is applicable on company Yes Yes
Cash flows from used in operating activities [Abstract]
Profit before extraordinary items and tax -4,30,35,759 -5,20,19,410
Adjustments for reconcile profit (loss) [Abstract]
Adjustments to profit (loss) [Abstract]
Adjustments for depreciation and amortisation expense 28,55,139 29,47,811
Adjustments for impairment loss reversal of impairment loss
4,951 72,247
recognised in profit or loss
Other adjustments for non-cash items (A) 11,482
0
Total adjustments to profit (loss) 28,71,572 30,20,058

Adjustments for working capital [Abstract]
Adjustments for decrease (increase) in inventories -3,08,122 2,28,082
Adjustments for decrease (increase) in trade receivables -1,45,655 -8,63,232
Adjustments for decrease (increase) in other current assets -94,464 7,91,685
Adjustments for increase (decrease) in trade payables 8,03,107 -11,75,419
Adjustments for increase (decrease) in other current liabilities 1,74,001 1,47,510
Adjustments for provisions 1,31,51,492 3,23,29,147
Total adjustments for working capital 1,35,80,359 3,14,57,773
Total adjustments for reconcile profit (loss) 1,64,51,931 3,44,77,831
Net cash flows from (used in) operations -2,65,83,828 -1,75,41,579
Interest paid -430 -1,04,56,641
Interest received -87,19,181 -1,13,25,755
Income taxes paid (refund) 61,30,124 2,82,65,763
Other inflows (outflows) of cash -6,14,043 -1,12,004
Net cash flows from (used in) operating activities before extraordinary
-4,20,46,746 -4,67,88,460
items
Net cash flows from (used in) operating activities -4,20,46,746 -4,67,88,460
Cash flows from used in investing activities [Abstract]
Proceeds from sales of tangible assets 12,686 1,42,378
Purchase of tangible assets 15,51,629 0
Interest received 91,58,734 1,08,21,862
Other inflows (outflows) of cash -24,88,79,525 -12,50,12,092
Net cash flows from (used in) investing activities before extraordinary
-24,12,59,734 -11,40,47,852
items
Net cash flows from (used in) investing activities -24,12,59,734 -11,40,47,852
Cash flows from used in financing activities [Abstract]
Proceeds from issuing shares 0 4,23,31,180
Proceeds from borrowings 0 46,02,70,000
Repayments of borrowings 0 3,00,00,000
Interest paid 430 1,12,71,983
Net cash flows from (used in) financing activities before extraordinary
-430 46,13,29,197
items
Net cash flows from (used in) financing activities -430 46,13,29,197
Net increase (decrease) in cash and cash equivalents before effect of
-28,33,06,910 30,04,92,885
exchange rate changes
Net increase (decrease) in cash and cash equivalents -28,33,06,910 30,04,92,885
Cash and cash equivalents cash flow statement at end of period 1,74,52,153 30,07,59,063 2,66,178
Footnotes
(A) Advances/debts written off
71
[200100] Notes - Share capital
Disclosure of shareholding more than five per cent in company [Table] ..(1)
Classes of share capital [Axis] Equity shares 1 [Member]
Name of shareholder [Axis] Shareholder 1 [Member] Shareholder 2 [Member]
01/04/2015 01/04/2014 01/04/2015 01/04/2014
to to to to
31/03/2016 31/03/2015 31/03/2016 31/03/2015
Disclosure of shareholding more than five per cent in
company [Abstract]
Disclosure of shareholding more than five per cent
in company [LineItems]
Type of share Equity Share Capital Equity Share Capital Equity Share Capital Equity Share Capital
MKCP Direct MKCP Direct
Name of shareholder Investments Investments G.Madhukar Reddy G.Madhukar Reddy
(Mauritius) IV Ltd (Mauritius) IV Ltd
PAN of shareholder AJEPG8481E AJEPG8481E
Country of incorporation or residence of
MAURITIUS MAURITIUS India India
shareholder
Number of shares held in company [shares] 87,340 [shares] 87,340 [shares] 33,280 [shares] 33,280
Percentage of shareholding in company 49.09% 49.09% 18.71% 18.71%
Classes of share capital [Axis] Equity shares 1 [Member]
01/04/2015 01/04/2014 01/04/2015 01/04/2014
to to to to
31/03/2016 31/03/2015 31/03/2016 31/03/2015
company [Abstract]
Type of share Equity Share Capital Equity Share Capital Equity Share Capital Equity Share Capital
IL & FS Trust IL & FS Trust IL & FS Trust
IL & FS Trust
Company Limited Company Limited (As Company Limited
Company Limited (As
Name of shareholder (As trustee of India trustee of India (As trustee of TVS
trustee of TVS Sriram
Venture Trust - Venture Trust - Fund- Sriram Growth Fund
Growth Fund I)
Fund- I) I) I)
PAN of shareholder AAATI6554P AAATI6554P AABTT5582H AABTT5582H
India India India India
shareholder
Number of shares held in company [shares] 16,173 [shares] 16,173 [shares] 18,834 [shares] 18,834
72
Classes of share capital [Axis] Equity shares 1 [Member] Preference shares 1 [Member]
01/04/2015 01/04/2014 01/04/2015 01/04/2014
to to to to
31/03/2016 31/03/2015 31/03/2016 31/03/2015
company [Abstract]
Redeemable Redeemable Redeemable Redeemable
Type of share preference shares preference shares
preference shares preference shares
IL & FS Trust IL & FS Trust
G.Madhukar Reddy G.Madhukar Reddy
Company Limited Company Limited (As
(As trustee of (As trustee of
Name of shareholder MedPlus Employees MedPlus Employees
(As trustee of TVS trustee of TVS
Shriram Growth Shriram Growth Fund
Benefit Trust) Benefit Trust)
Fund I) I)
PAN of shareholder AJEPG8481E AJEPG8481E AAATI6554P AAATI6554P
shareholder
Number of shares held in company [shares] 9,673 [shares] 9,673 [shares] 40,00,000 [shares] 40,00,000
Classes of share capital [Axis] Preference shares 1 [Member]
01/04/2015 01/04/2014 01/04/2015 01/04/2014
to to to to
31/03/2016 31/03/2015 31/03/2016 31/03/2015
company [Abstract]
Redeemable Redeemable Redeemable Redeemable
Type of share preference shares preference shares preference shares preference shares
IL & FS Trust IL & FS Trust IL & FS Trust IL & FS Trust
Company Limited Company Limited (As Company Limited Company Limited (As
Name of shareholder (As trustee of India trustee of India (As trustee of India trustee of India
Venture Trust – Venture Trust – Fund Venture Trust – Venture Trust – Fund
Fund I) I) Fund II) II)
PAN of shareholder AABTT5582H AABTT5582H AABTI1118C AABTI1118C
shareholder
Number of shares held in company [shares] 40,00,000 [shares] 40,00,000 [shares] 40,00,000 [shares] 40,00,000
73
Disclosure of classes of share capital [Table] ..(1)

Equity shares
Classes of share capital [Axis] Share capital [Member]
[Member]
01/04/2015 01/04/2014 01/04/2015
to to 31/03/2014 to
31/03/2016 31/03/2015 31/03/2016
Disclosure of classes of share capital [Abstract]
Disclosure of classes of share capital [LineItems]
Number of shares authorised [shares] 1,24,20,000 [shares] 1,24,20,000 [shares] 1,85,000
Value of shares authorised 12,42,00,000 12,42,00,000 18,50,000
Number of shares issued [shares] 1,24,01,351 [shares] 1,24,01,351 [shares] 1,68,233
Value of shares issued 12,40,13,510 12,40,13,510 16,82,330
Number of shares subscribed and fully paid [shares] 1,24,01,351 [shares] 1,24,01,351 [shares] 1,68,233
Value of shares subscribed and fully paid 12,40,13,510 12,40,13,510 16,82,330
Number of shares subscribed but not fully paid [shares] 0 [shares] 0 [shares] 0
Value of shares subscribed but not fully paid 0 0 0
Total number of shares subscribed [shares] 1,24,01,351 [shares] 1,24,01,351 [shares] 1,68,233
Total value of shares subscribed 12,40,13,510 12,40,13,510 16,82,330
Value of shares paid-up [Abstract]
Number of shares paid-up [shares] 1,24,01,351 [shares] 1,24,01,351 [shares] 1,68,233
Value of shares called 12,40,13,510 12,40,13,510 16,82,330
Value of shares paid-up 12,40,13,510 12,40,13,510 16,82,330
Reconciliation of number of shares outstanding
[Abstract]
Changes in number of shares outstanding
[Abstract]
Increase in number of shares outstanding
[Abstract]
Number of shares issued in public offering [shares] 0 [shares] 0 [shares] 0
Number of shares issued as bonus shares [shares] 0 [shares] 0 [shares] 0
Number of shares issued as rights [shares] 0 [shares] 0 [shares] 0
Number of shares issued in private
placement arising out of conversion of
[shares] 0 [shares] 0 [shares] 0
debentures preference shares during
period
Number of shares issued in other private
placement
Number of shares issued as preferential
allotment arising out of conversion of
period
Number of shares issued as other
preferential allotment
Number of shares allotted for
contracts without payment received [shares] 0 [shares] 0 [shares] 0
in cash
Number of shares issued under scheme of
amalgamation
Number of other issues of shares [shares] 0 [shares] 1,22,33,118 [shares] 0
Number of shares issued under employee
stock option plan
Number of other issue of shares
arising out of conversion of [shares] 0 [shares] 0 [shares] 0
securities
Total aggregate number of shares issued
[shares] 0 [shares] 1,22,33,118 [shares] 0
during period
Decrease in number of shares during period
[Abstract]
Number of shares redeemed [shares] 0 [shares] 0
Number of shares bought back [shares] 0 [shares] 0 [shares] 0
Other decrease in number of shares [shares] 9,673 [shares] 9,673 [shares] 9,673
Total decrease in number of shares during
[shares] 9,673 [shares] 9,673 [shares] 9,673
period
Total increase (decrease) in number of
[shares] -9,673 [shares] 1,22,23,445 [shares] -9,673
shares outstanding
Number of shares outstanding at end of period [shares] 1,24,01,351 [shares] 1,24,01,351 [shares] 1,77,906 [shares] 1,77,906
74
Reconciliation of value of shares outstanding

[Abstract]
Changes in share capital [Abstract]
Increase in share capital during period
[Abstract]
Amount of public issue during period 0 0 0
Amount of bonus issue during period 0 0 0
Amount of rights issue during period 0 0 0
Amount of private placement issue
arising out of conversion of debentures 0 0 0
preference shares during period
Amount of other private placement issue
0 0 0
during period
Amount of preferential allotment issue
Amount of other preferential allotment
0 0 0
issue during period
Amount of issue allotted for
contracts without payment 0 0 0
received in cash during period
Amount of issue under scheme of
0 0 0
amalgamation during period
Amount of other issues during period 0 12,23,31,180 0
Amount of employee stock option plan
0 0 0
issued during period
Amount of other issue arising out of
conversion of securities during 0 0 0
period
Total aggregate amount of increase in
0 12,23,31,180 0
share capital during period
Decrease in share capital during period
[Abstract]
Decrease in amount of shares redeemed 0 0
Decrease in amount of shares bought back 0 0 0
Other decrease in amount of shares 96,730 96,730 96,730
Total decrease in share capital during
96,730 96,730 96,730
period
Total increase (decrease) in share capital -96,730 12,22,34,450 -96,730
Share capital at end of period 12,40,13,510 12,40,13,510 17,79,060 16,82,330
Details of application money received for
allotment of securities and due for refund and
interest accrued thereon [Abstract]
Application money received for allotment of
securities and due for refund and interest
accrued thereon [Abstract]
Application money received for
allotment of securities and due for 0 0 0
refund, principal
refund, interest accrued
Total application money received for
allotment of securities and due for refund 0 0 0
and interest accrued thereon
75

Classes of share capital [Axis] Equity shares [Member] Equity shares 1 [Member]
01/04/2014 01/04/2015 01/04/2014
to 31/03/2014 to to
31/03/2015 31/03/2016 31/03/2015
Type of share Equity Share Capital Equity Share Capital
Number of shares authorised [shares] 1,85,000 [shares] 1,85,000 [shares] 1,85,000
Value of shares authorised 18,50,000 18,50,000 18,50,000
Number of shares issued [shares] 1,68,233 [shares] 1,68,233 [shares] 1,68,233
Value of shares issued 16,82,330 16,82,330 16,82,330
Number of shares subscribed and fully paid [shares] 1,68,233 [shares] 1,68,233 [shares] 1,68,233
Value of shares subscribed and fully paid 16,82,330 16,82,330 16,82,330
Number of shares subscribed but not fully paid [shares] 0 [shares] 0 [shares] 0
Value of shares subscribed but not fully paid 0 0 0
Total number of shares subscribed [shares] 1,68,233 [shares] 1,68,233 [shares] 1,68,233
Total value of shares subscribed 16,82,330 16,82,330 16,82,330
Number of shares paid-up [shares] 1,68,233 [shares] 1,68,233 [shares] 1,68,233
Value of shares called 16,82,330 16,82,330 16,82,330
Value of shares paid-up 16,82,330 16,82,330 16,82,330
Par value per share [INR/shares] 10 [INR/shares] 10
Amount per share called in case shares not fully
[INR/shares] 0 [INR/shares] 0
called
[Abstract]
[Abstract]
[Abstract]
Number of shares issued in public offering [shares] 0 [shares] 0 [shares] 0
Number of shares issued as bonus shares [shares] 0 [shares] 0 [shares] 0
Number of shares issued as rights [shares] 0 [shares] 0 [shares] 0
period
placement
period
contracts without payment received [shares] 0 [shares] 0 [shares] 0
in cash
amalgamation
Number of other issues of shares [shares] 0 [shares] 0 [shares] 0
stock option plan
arising out of conversion of [shares] 0 [shares] 0 [shares] 0
securities
during period
[Abstract]
Number of shares bought back [shares] 0 [shares] 0 [shares] 0
Other decrease in number of shares [shares] 9,673 [shares] 9,673 [shares] 9,673
[shares] 9,673 [shares] 9,673 [shares] 9,673
period
76

[shares] -9,673 [shares] -9,673 [shares] -9,673
shares outstanding
Number of shares outstanding at end of period [shares] 1,77,906 [shares] 1,77,906 [shares] 1,77,906 [shares] 1,77,906
[Abstract]
[Abstract]
Amount of public issue during period 0 0 0
Amount of bonus issue during period 0 0 0
Amount of rights issue during period 0 0 0
0 0 0
during period
0 0 0
issue during period
contracts without payment 0 0 0
0 0 0
Amount of other issues during period 0 0 0
0 0 0
conversion of securities during 0 0 0
period
0 0 0
[Abstract]
Decrease in amount of shares bought back 0 0 0
Other decrease in amount of shares 96,730 96,730 96,730
96,730 96,730 96,730
period
Total increase (decrease) in share capital -96,730 -96,730 -96,730
Share capital at end of period 16,82,330 17,79,060 16,82,330 16,82,330
refund, principal
allotment of securities and due for refund 0 0 0
77

Equity shares 1
Classes of share capital [Axis] Preference shares [Member]
[Member]
01/04/2015 01/04/2014
31/03/2014 to to 31/03/2014
31/03/2016 31/03/2015
Number of shares authorised [shares] 1,22,35,000 [shares] 1,22,35,000
Value of shares authorised 12,23,50,000 12,23,50,000
Number of shares issued [shares] 1,22,33,118 [shares] 1,22,33,118
Value of shares issued 12,23,31,180 12,23,31,180
Number of shares subscribed and fully paid [shares] 1,22,33,118 [shares] 1,22,33,118
Value of shares subscribed and fully paid 12,23,31,180 12,23,31,180
Number of shares subscribed but not fully paid [shares] 0 [shares] 0
Value of shares subscribed but not fully paid 0 0
Total number of shares subscribed [shares] 1,22,33,118 [shares] 1,22,33,118
Total value of shares subscribed 12,23,31,180 12,23,31,180
Number of shares paid-up [shares] 1,22,33,118 [shares] 1,22,33,118
Value of shares called 12,23,31,180 12,23,31,180
Value of shares paid-up 12,23,31,180 12,23,31,180
[Abstract]
[Abstract]
[Abstract]
Number of shares issued in public offering [shares] 0 [shares] 0
Number of shares issued as bonus shares [shares] 0 [shares] 0
[shares] 0 [shares] 0
period
placement
period
contracts without payment received [shares] 0 [shares] 0
in cash
amalgamation
Number of other issues of shares [shares] 0 [shares] 1,22,33,118
stock option plan
arising out of conversion of [shares] 0 [shares] 0
securities
[shares] 0 [shares] 1,22,33,118
during period
[Abstract]
Number of shares bought back [shares] 0 [shares] 0
Other decrease in number of shares [shares] 0 [shares] 0
period
[shares] 0 [shares] 1,22,33,118
shares outstanding
Number of shares outstanding at end of period [shares] 1,77,906 [shares] 1,22,33,118 [shares] 1,22,33,118 [shares] 0
78

[Abstract]
[Abstract]
Amount of public issue during period 0 0
Amount of bonus issue during period 0 0
arising out of conversion of debentures 0 0
0 0
during period
arising out of conversion of debentures 0 0
0 0
issue during period
contracts without payment 0 0
0 0
Amount of other issues during period 0 12,23,31,180
0 0
conversion of securities during 0 0
period
0 12,23,31,180
[Abstract]
Decrease in amount of shares bought back 0 0
Other decrease in amount of shares 0 0
0 0
period
Total increase (decrease) in share capital 0 12,23,31,180
Share capital at end of period 17,79,060 12,23,31,180 12,23,31,180 0
allotment of securities and due for 0 0
refund, principal
allotment of securities and due for 0 0
allotment of securities and due for refund 0 0
79

Classes of share capital [Axis] Preference shares 1 [Member]
01/04/2015 01/04/2014
to to 31/03/2014
31/03/2016 31/03/2015
Redeemable Preference Redeemable Preference
Type of share Shares Shares
Number of shares authorised [shares] 1,22,35,000 [shares] 1,22,35,000
Value of shares authorised 12,23,50,000 12,23,50,000
Number of shares issued [shares] 1,22,33,118 [shares] 1,22,33,118
Value of shares issued 12,23,31,180 12,23,31,180
Number of shares subscribed and fully paid [shares] 1,22,33,118 [shares] 1,22,33,118
Value of shares subscribed and fully paid 12,23,31,180 12,23,31,180
Number of shares subscribed but not fully paid [shares] 0 [shares] 0
Value of shares subscribed but not fully paid 0 0
Total number of shares subscribed [shares] 1,22,33,118 [shares] 1,22,33,118
Total value of shares subscribed 12,23,31,180 12,23,31,180
Number of shares paid-up [shares] 1,22,33,118 [shares] 1,22,33,118
Value of shares called 12,23,31,180 12,23,31,180
Value of shares paid-up 12,23,31,180 12,23,31,180
Par value per share [INR/shares] 10 [INR/shares] 10
Amount per share called in case shares not fully called [INR/shares] 0 [INR/shares] 0
Reconciliation of number of shares outstanding [Abstract]
Changes in number of shares outstanding [Abstract]
Increase in number of shares outstanding [Abstract]
Number of shares issued in public offering [shares] 0 [shares] 0
Number of shares issued as bonus shares [shares] 0 [shares] 0
Number of shares issued in private placement
arising out of conversion of debentures [shares] 0 [shares] 0
Number of shares issued in other private placement [shares] 0 [shares] 0
Number of shares issued as preferential allotment
arising out of conversion of debentures [shares] 0 [shares] 0
Number of shares issued as other preferential allotment [shares] 0 [shares] 0
Number of shares allotted for contracts without payment
received in cash
Number of shares issued under scheme of amalgamation [shares] 0 [shares] 0
Number of other issues of shares [shares] 0 [shares] 1,22,33,118
Number of shares issued under employee stock option plan [shares] 0 [shares] 0
Number of other issue of shares arising out of conversion
of securities
Total aggregate number of shares issued during period [shares] 0 [shares] 1,22,33,118
Decrease in number of shares during period [Abstract]
Number of shares bought back [shares] 0 [shares] 0
Other decrease in number of shares [shares] 0 [shares] 0
Total decrease in number of shares during period [shares] 0 [shares] 0
Total increase (decrease) in number of shares outstanding [shares] 0 [shares] 1,22,33,118
Number of shares outstanding at end of period [shares] 1,22,33,118 [shares] 1,22,33,118 [shares] 0
Reconciliation of value of shares outstanding [Abstract]
Increase in share capital during period [Abstract]
Amount of public issue during period 0 0
Amount of bonus issue during period 0 0
Amount of private placement issue arising out of
conversion of debentures preference shares during 0 0
period
Amount of other private placement issue during period 0 0
80
Amount of preferential allotment issue arising out

of conversion of debentures preference shares 0 0
during period
Amount of other preferential allotment issue during period 0 0
Amount of issue allotted for contracts without payment
0 0
Amount of issue under scheme of amalgamation during period 0 0
Amount of other issues during period 0 12,23,31,180
Amount of employee stock option plan issued during period 0 0
Amount of other issue arising out of conversion of
0 0
securities during period
Total aggregate amount of increase in share capital during
0 12,23,31,180
period
Decrease in share capital during period [Abstract]
Decrease in amount of shares bought back 0 0
Other decrease in amount of shares 0 0
Total decrease in share capital during period 0 0
Total increase (decrease) in share capital 0 12,23,31,180
Share capital at end of period 12,23,31,180 12,23,31,180 0
Details of application money received for allotment of
securities and due for refund and interest accrued thereon
[Abstract]
Application money received for allotment of securities
and due for refund and interest accrued thereon [Abstract]
Application money received for allotment of securities and
0 0
due for refund, principal
Application money received for allotment of securities
0 0
and due for refund, interest accrued
Total application money received for allotment of
securities and due for refund and interest accrued 0 0
thereon

01/04/2015 01/04/2014
to to
31/03/2016 31/03/2015
Disclosure of notes on share capital explanatory [TextBlock]
Whether there are any shareholders holding more than five per cent
Yes Yes
shares in company
Whether money raised from public offering during year No Yes
Amount raised from public offering during year 0 12,23,31,180
Amount utilised towards specified purposes for public offering 0 12,23,31,180
Amount remaining unutilised received in respect of public offering 0 0
81
[200200] Notes - Reserves and surplus
Statement of changes in reserves [Table] ..(1)

Securities premium
Components of reserves [Axis] Reserves [Member]
account [Member]
01/04/2015 01/04/2014 01/04/2015
to to 31/03/2014 to
31/03/2016 31/03/2015 31/03/2016
Statement of changes in reserves [Abstract]
Statement of changes in reserves [LineItems]
Changes in reserves [Abstract]
Additions to reserves [Abstract]
Profit (loss) for period -4,30,35,759 -5,20,19,410
Other additions to reserves 2,73,82,408 1,32,58,815
Total additions to reserves -1,56,53,351 -3,87,60,595
Deductions to reserves [Abstract]
Other deductions to reserves 23,72,38,993 13,00,32,725 22,29,18,037
Total deductions to reserves 23,72,38,993 13,00,32,725 22,29,18,037
Total changes in reserves -25,28,92,344 -16,87,93,320 -22,29,18,037
Reserves at end of period 108,24,85,425 125,79,41,813 142,67,35,133 165,73,40,208

Employee stock options outstanding
Components of reserves [Axis] Securities premium account [Member]
[Member]
01/04/2014 01/04/2015 01/04/2014
to 31/03/2014 to to
31/03/2015 31/03/2016 31/03/2015
Other additions to reserves 1,30,61,452 1,32,58,815
Total additions to reserves 1,30,61,452 1,32,58,815
Other deductions to reserves 12,98,80,781 1,43,20,956
Total deductions to reserves 12,98,80,781 1,43,20,956
Total changes in reserves -12,98,80,781 -12,59,504 1,32,58,815

Employee stock
Components of reserves [Axis] options outstanding Other reserves [Member]
[Member]
01/04/2015 01/04/2014
31/03/2014 to to 31/03/2014
31/03/2016 31/03/2015
Other additions to reserves 1,43,20,956
Total additions to reserves 1,43,20,956
Total changes in reserves 1,43,20,956 0
82

Components of reserves [Axis] General reserve [Member] Surplus [Member]
01/04/2015 01/04/2014 01/04/2015
to to 31/03/2014 to
31/03/2016 31/03/2015 31/03/2016
Profit (loss) for period -4,30,35,759
Other additions to reserves 1,43,20,956
Total additions to reserves 1,43,20,956 -4,30,35,759
Total changes in reserves 1,43,20,956 0 -4,30,35,759
Reserves at end of period 2,86,41,912 1,43,20,956 1,43,20,956 -66,07,72,259

Components of reserves [Axis] Surplus [Member]
01/04/2014
to 31/03/2014
31/03/2015
Profit (loss) for period -5,20,19,410
Total additions to reserves -5,20,19,410
Other deductions to reserves 1,51,944
Total deductions to reserves 1,51,944
Total changes in reserves -5,21,71,354
Reserves at end of period -61,77,36,500 -56,55,65,146
[200300] Notes - Borrowings
Classification of borrowings [Table] ..(1)

Classification based on time period [Axis] Long-term [Member]
Classification of borrowings [Axis] Borrowings [Member] Other loans and advances [Member]
Subclassification of borrowings [Axis] Unsecured borrowings [Member] Unsecured borrowings [Member]
31/03/2016 31/03/2015 31/03/2016 31/03/2015
Borrowings notes [Abstract]
Details of borrowings [Abstract]
Details of borrowings [LineItems]
Borrowings 43,02,70,000 43,02,70,000 43,02,70,000 43,02,70,000
Details on loans guaranteed [Abstract]
Aggregate amount of loans guaranteed by
0 0 0 0
directors
Aggregate amount of loans guaranteed by
0 0 0 0
others
Details on defaults on borrowings [Abstract]
Outstanding amount of continuing default
0 0 0 0
principal
Outstanding amount of continuing default
0 0 0 0
interest
83
Classification of borrowings [Table] ..(2)

Other loans and advances, others
Classification of borrowings [Axis]
[Member]
Subclassification of borrowings [Axis] Unsecured borrowings [Member]
31/03/2016 31/03/2015
Borrowings notes [Abstract]
Details of borrowings [Abstract]
Details of borrowings [LineItems]
Borrowings 43,02,70,000 43,02,70,000
Details on loans guaranteed [Abstract]
Aggregate amount of loans guaranteed by directors 0 0
Aggregate amount of loans guaranteed by others 0 0
Details on defaults on borrowings [Abstract]
Outstanding amount of continuing default principal 0 0
Outstanding amount of continuing default interest 0 0
84
[201000] Notes - Tangible assets
Disclosure of tangible assets [Table] ..(1)

Classes of tangible assets [Axis] Company total tangible assets [Member]
Sub classes of tangible assets [Axis] Owned and leased assets [Member]
Carrying amount accumulated depreciation and gross
Carrying amount [Member] Gross carrying amount [Member]
carrying amount [Axis]
01/04/2015 01/04/2014 01/04/2015 01/04/2014
to to 31/03/2014 to to 31/03/2014
31/03/2016 31/03/2015 31/03/2016 31/03/2015
Disclosure of tangible assets [Abstract]
Disclosure of tangible assets
[LineItems]
Reconciliation of changes in
tangible assets [Abstract]
Changes in tangible assets
[Abstract]
Additions other than through
business combinations tangible 15,51,629 0 15,51,629 0
assets
Acquisitions through
business combinations 0 0 0 0
tangible assets
Depreciation tangible assets -28,55,139 -29,47,811
Impairment loss
recognised in profit or 0 0
loss tangible assets
Reversal of impairment loss
recognised in profit or loss 0 0
tangible assets
Revaluation increase
0 0 0 0
(decrease) tangible assets
Disposals tangible assets
[Abstract]
0 0 0 0
through demergers
Disposals tangible assets,
17,637 5,16,839 34,87,186 3,64,895
others
Total disposals tangible
17,637 5,16,839 34,87,186 3,64,895
assets
Other adjustments tangible
assets [Abstract]
Increase (decrease) through
net exchange differences 0 0 0 0
tangible assets
0 1,50,270 0 0
assets, others
Total other adjustments
0 1,50,270 0 0
tangible assets
Total changes in tangible
-13,21,147 -33,14,380 -19,35,557 -3,64,895
assets
Tangible assets at end of period 72,93,487 86,14,634 1,19,29,014 1,94,34,796 2,13,70,353 2,17,35,248
85

Sub classes of tangible assets [Axis] Owned and leased assets [Member] Owned assets [Member]
Carrying amount accumulated depreciation and gross Accumulated depreciation and impairment
Carrying amount [Member]
carrying amount [Axis] [Member]
01/04/2015 01/04/2014 01/04/2015 01/04/2014
to to 31/03/2014 to to 31/03/2014
31/03/2016 31/03/2015 31/03/2016 31/03/2015
[LineItems]
[Abstract]
business combinations tangible 15,51,629 0
assets
business combinations 0 0
tangible assets
Depreciation tangible assets 28,55,139 29,47,811 -28,55,139 -29,47,811
Impairment loss
recognised in profit or 0 0 0 0
recognised in profit or loss 0 0 0 0
tangible assets
0 0
[Abstract]
0 0 0 0
through demergers
34,69,549 -1,51,944 17,637 5,16,839
others
34,69,549 -1,51,944 17,637 5,16,839
assets
assets [Abstract]
net exchange differences 0 0
tangible assets
0 -1,50,270 0 1,50,270
assets, others
0 -1,50,270 0 1,50,270
tangible assets
-6,14,410 29,49,485 -13,21,147 -33,14,380
assets
Tangible assets at end of period 1,21,41,309 1,27,55,719 98,06,234 72,93,487 86,14,634 1,19,29,014
86

Sub classes of tangible assets [Axis] Owned assets [Member]
Gross carrying amount [Member]
01/04/2015 01/04/2014 01/04/2015 01/04/2014
to to 31/03/2014 to to 31/03/2014
31/03/2016 31/03/2015 31/03/2016 31/03/2015
[LineItems]
[Abstract]
assets
tangible assets
Depreciation tangible assets 28,55,139 29,47,811
Impairment loss
tangible assets
0 0
[Abstract]
0 0 0 0
through demergers
34,87,186 3,64,895 34,69,549 -1,51,944
others
34,87,186 3,64,895 34,69,549 -1,51,944
assets
assets [Abstract]
tangible assets
0 0 0 -1,50,270
assets, others
0 0 0 -1,50,270
tangible assets
-19,35,557 -3,64,895 -6,14,410 29,49,485
assets
Tangible assets at end of period 1,94,34,796 2,13,70,353 2,17,35,248 1,21,41,309 1,27,55,719 98,06,234
87

Classes of tangible assets [Axis] Plant and equipment [Member]
01/04/2015 01/04/2014 01/04/2015 01/04/2014
to to 31/03/2014 to to 31/03/2014
31/03/2016 31/03/2015 31/03/2016 31/03/2015
[LineItems]
[Abstract]
business combinations tangible 9,05,189 0 9,05,189 0
assets
tangible assets
Impairment loss
tangible assets
0 0 0 0
[Abstract]
0 0 0 0
through demergers
0 4,15,154 0 3,64,895
others
0 4,15,154 0 3,64,895
assets
assets [Abstract]
tangible assets
0 1,50,270 0 0
assets, others
0 1,50,270 0 0
tangible assets
-12,71,280 -25,81,373 9,05,189 -3,64,895
assets
Tangible assets at end of period 54,28,719 66,99,999 92,81,372 1,41,91,097 1,32,85,908 1,36,50,803
88

Classes of tangible assets [Axis] Plant and equipment [Member] Other plant and equipment [Member]
Sub classes of tangible assets [Axis] Owned assets [Member] Owned assets [Member]
01/04/2015 01/04/2014 01/04/2015 01/04/2014
to to 31/03/2014 to to 31/03/2014
31/03/2016 31/03/2015 31/03/2016 31/03/2015
[LineItems]
[Abstract]
assets
tangible assets
Depreciation tangible assets 21,76,469 23,16,489 -21,76,469 -23,16,489
Impairment loss
tangible assets
0 0
[Abstract]
0 0 0 0
through demergers
0 -50,259 0 4,15,154
others
0 -50,259 0 4,15,154
assets
assets [Abstract]
tangible assets
0 -1,50,270 0 1,50,270
assets, others
0 -1,50,270 0 1,50,270
tangible assets
21,76,469 22,16,478 -12,71,280 -25,81,373
assets
Tangible assets at end of period 87,62,378 65,85,909 43,69,431 54,28,719 66,99,999 92,81,372
89

Classes of tangible assets [Axis] Other plant and equipment [Member]
01/04/2015 01/04/2014 01/04/2015 01/04/2014
to to 31/03/2014 to to 31/03/2014
31/03/2016 31/03/2015 31/03/2016 31/03/2015
[LineItems]
[Abstract]
assets
tangible assets
Depreciation tangible assets 21,76,469 23,16,489
Impairment loss
tangible assets
0 0
[Abstract]
0 0 0 0
through demergers
0 3,64,895 0 -50,259
others
0 3,64,895 0 -50,259
assets
assets [Abstract]
tangible assets
0 0 0 -1,50,270
assets, others
0 0 0 -1,50,270
tangible assets
9,05,189 -3,64,895 21,76,469 22,16,478
assets
Tangible assets at end of period 1,41,91,097 1,32,85,908 1,36,50,803 87,62,378 65,85,909 43,69,431
90

Classes of tangible assets [Axis] Furniture and fixtures [Member]
01/04/2015 01/04/2014 01/04/2015 01/04/2014
to to 31/03/2014 to to 31/03/2014
31/03/2016 31/03/2015 31/03/2016 31/03/2015
[LineItems]
[Abstract]
business combinations tangible 0 0 0 0
assets
tangible assets
Impairment loss
tangible assets
0 0 0 0
[Abstract]
0 0 0 0
through demergers
0 0 0 0
others
0 0 0 0
assets
assets [Abstract]
tangible assets
0 0 0 0
assets, others
0 0 0 0
tangible assets
-5,32,149 -5,32,194 0 0
assets
91

Classes of tangible assets [Axis] Furniture and fixtures [Member] Vehicles [Member]
01/04/2015 01/04/2014 01/04/2015 01/04/2014
to to 31/03/2014 to to 31/03/2014
31/03/2016 31/03/2015 31/03/2016 31/03/2015
[LineItems]
[Abstract]
business combinations tangible 0 0
assets
tangible assets
Depreciation tangible assets 5,32,149 5,32,194 -66,559 -67,023
Impairment loss
tangible assets
0 0
[Abstract]
0 0 0 0
through demergers
0 0 17,637 0
others
0 0 17,637 0
assets
assets [Abstract]
tangible assets
0 0 0 0
assets, others
0 0 0 0
tangible assets
5,32,149 5,32,194 -84,196 -67,023
assets
92

Classes of tangible assets [Axis] Vehicles [Member]
01/04/2015 01/04/2014 01/04/2015 01/04/2014
to to 31/03/2014 to to 31/03/2014
31/03/2016 31/03/2015 31/03/2016 31/03/2015
[LineItems]
[Abstract]
business combinations tangible 0 0
assets
tangible assets
Depreciation tangible assets 66,559 67,023
Impairment loss
tangible assets
0 0
[Abstract]
0 0 0 0
through demergers
37,783 0 20,146 0
others
37,783 0 20,146 0
assets
assets [Abstract]
tangible assets
0 0 0 0
assets, others
0 0 0 0
tangible assets
-37,783 0 46,413 67,023
assets
93

Classes of tangible assets [Axis] Motor vehicles [Member]
01/04/2015 01/04/2014 01/04/2015 01/04/2014
to to 31/03/2014 to to 31/03/2014
31/03/2016 31/03/2015 31/03/2016 31/03/2015
[LineItems]
[Abstract]
business combinations tangible 0 0 0 0
assets
tangible assets
Depreciation tangible assets -66,559 -67,023
Impairment loss
tangible assets
0 0 0 0
[Abstract]
0 0 0 0
through demergers
17,637 0 37,783 0
others
17,637 0 37,783 0
assets
assets [Abstract]
tangible assets
0 0 0 0
assets, others
0 0 0 0
tangible assets
-84,196 -67,023 -37,783 0
assets
94

Classes of tangible assets [Axis] Motor vehicles [Member] Leasehold improvements [Member]
01/04/2015 01/04/2014 01/04/2015 01/04/2014
to to 31/03/2014 to to 31/03/2014
31/03/2016 31/03/2015 31/03/2016 31/03/2015
[LineItems]
[Abstract]
assets
tangible assets
Depreciation tangible assets 66,559 67,023 -53,316 0
Impairment loss
tangible assets
0 0
[Abstract]
0 0 0 0
through demergers
20,146 0 0 0
others
20,146 0 0 0
assets
assets [Abstract]
tangible assets
0 0 0 0
assets, others
0 0 0 0
tangible assets
46,413 67,023 5,62,524 0
assets
Tangible assets at end of period 3,02,591 2,56,178 1,89,155 5,62,524 0 0
95

Classes of tangible assets [Axis] Leasehold improvements [Member]
01/04/2015 01/04/2014 01/04/2015 01/04/2014
to to 31/03/2014 to to 31/03/2014
31/03/2016 31/03/2015 31/03/2016 31/03/2015
[LineItems]
[Abstract]
assets
tangible assets
Depreciation tangible assets 53,316 0
Impairment loss
tangible assets
0 0
[Abstract]
0 0 0 0
through demergers
34,49,403 0 34,49,403 0
others
34,49,403 0 34,49,403 0
assets
assets [Abstract]
tangible assets
0 0 0 0
assets, others
0 0 0 0
tangible assets
-28,33,563 0 -33,96,087 0
assets
Tangible assets at end of period 6,15,840 34,49,403 34,49,403 53,316 34,49,403 34,49,403
96

Classes of tangible assets [Axis] Other tangible assets [Member]
01/04/2015 01/04/2014 01/04/2015 01/04/2014
to to 31/03/2014 to to 31/03/2014
31/03/2016 31/03/2015 31/03/2016 31/03/2015
[LineItems]
[Abstract]
business combinations tangible 30,600 0 30,600 0
assets
tangible assets
Depreciation tangible assets -26,646 -32,105
Impairment loss
tangible assets
0 0 0 0
[Abstract]
0 0 0 0
through demergers
0 1,01,685 0 0
others
0 1,01,685 0 0
assets
assets [Abstract]
tangible assets
0 0 0 0
assets, others
0 0 0 0
tangible assets
3,954 -1,33,790 30,600 0
assets
Tangible assets at end of period 25,858 21,904 1,55,694 13,33,055 13,02,455 13,02,455
97

Classes of tangible assets [Axis] Other tangible assets [Member] Other tangible assets, others [Member]
Carrying amount accumulated depreciation and Accumulated depreciation and impairment
gross carrying amount [Axis] [Member]
01/04/2015 01/04/2014 01/04/2015 01/04/2014
to to 31/03/2014 to to 31/03/2014
31/03/2016 31/03/2015 31/03/2016 31/03/2015
[LineItems]
Data processing Data processing
Nature of other tangible assets equipment equipment
[Abstract]
business combinations tangible 30,600 0
assets
tangible assets
Depreciation tangible assets 26,646 32,105 -26,646 -32,105
Impairment loss
tangible assets
0 0
[Abstract]
0 0 0 0
through demergers
0 -1,01,685 0 1,01,685
others
0 -1,01,685 0 1,01,685
assets
assets [Abstract]
tangible assets
0 0 0 0
assets, others
0 0 0 0
tangible assets
26,646 1,33,790 3,954 -1,33,790
assets
Tangible assets at end of period 13,07,197 12,80,551 11,46,761 25,858 21,904 1,55,694
98

Classes of tangible assets [Axis] Other tangible assets, others [Member]
Carrying amount accumulated depreciation and Accumulated depreciation and impairment
gross carrying amount [Axis] [Member]
01/04/2015 01/04/2014 01/04/2015 01/04/2014
to to 31/03/2014 to to 31/03/2014
31/03/2016 31/03/2015 31/03/2016 31/03/2015
[LineItems]
Data processing Data processing Data processing Data processing
Nature of other tangible assets equipment equipment equipment equipment
[Abstract]
business combinations tangible 30,600 0
assets
tangible assets
Depreciation tangible assets 26,646 32,105
Impairment loss
tangible assets
0 0
[Abstract]
0 0 0 0
through demergers
0 0 0 -1,01,685
others
0 0 0 -1,01,685
assets
assets [Abstract]
tangible assets
0 0 0 0
assets, others
0 0 0 0
tangible assets
30,600 0 26,646 1,33,790
assets
99
Disclosure of additional information tangible assets [Table] ..(1)

Company total tangible assets Other plant and equipment Furniture and fixtures
Classes of tangible assets [Axis]
[Member] [Member] [Member]
Sub classes of tangible assets [Axis] Owned assets [Member] Owned assets [Member] Owned assets [Member]
01/04/2015 01/04/2014 01/04/2015 01/04/2014 01/04/2015 01/04/2014
to to to to to to
31/03/2016 31/03/2015 31/03/2016 31/03/2015 31/03/2016 31/03/2015
Disclosure of additional information
tangible assets [LineItems]
straight-line
Depreciation method tangible assets straight-line basis straight-line basis straight-line basis straight-line basis straight-line basis
basis
lives prescribed lives prescribed lives prescribed lives prescribed lives prescribed lives prescribed
under the under the under the under the under the under the
Useful lives or depreciation rates
schedule II to the schedule II to the schedule II to the schedule II to the schedule II to the schedule II to
tangible assets Companies Act, Companies Act, Companies Act, Companies Act, Companies Act, the Companies
2013. 2013. 2013. 2013. 2013. Act, 2013.
Disclosure of additional information tangible assets [Table] ..(2)

Leasehold improvements Other tangible assets, others
Classes of tangible assets [Axis] Motor vehicles [Member]
[Member] [Member]
Sub classes of tangible assets [Axis] Owned assets [Member] Owned assets [Member] Owned assets [Member]
01/04/2015 01/04/2014 01/04/2015 01/04/2014 01/04/2015 01/04/2014
to to to to to to
31/03/2016 31/03/2015 31/03/2016 31/03/2015 31/03/2016 31/03/2015
tangible assets [LineItems]
Depreciation on Depreciation on
leasehold leasehold
improvements is improvements is straight-line
Depreciation method tangible assets straight-line basis straight-line basis
provided over the provided over the
straight-line basis
basis
lease term or 5 lease term or 5
years years
lives prescribed lives prescribed t h e rates the r a t e s lives prescribed lives prescribed
under the under the prescribed under prescribed under under the under the
Useful lives or depreciation rates
schedule II to the schedule II to the the schedule II to the schedule II to schedule II to the schedule II to
tangible assets Companies Act, Companies Act, the Companies the Companies Companies Act, the Companies
2013. 2013. Act, 2013. Act, 2013. 2013. Act, 2013.
[201100] Notes - Intangible assets
Disclosure of intangible assets [Table] ..(1)

Company total intangible assets
Classes of intangible assets [Axis]
[Member]
Internally generated and other than
Sub classes of intangible assets [Axis] internally generated intangible assets
[Member]
Carrying amount accumulated amortization and impairment and gross carrying amount [Axis] Carrying amount [Member]
31/03/2016 31/03/2015
Disclosure of intangible assets [Abstract]
Disclosure of intangible assets [LineItems]
Reconciliation of changes in intangible assets [Abstract]
Intangible assets at end of period 0 0
100
[200400] Notes - Non-current investments
Details of non-current investments [Table] ..(1)

Classification of non-current investments [Axis] Column 1 Column 2
01/04/2015 01/04/2014 01/04/2015 01/04/2014
to to to to
31/03/2016 31/03/2015 31/03/2016 31/03/2015
Non-current investments [Abstract]
Disclosure of details of non-current investments
[Abstract]
Details of non-current investments [LineItems]
Investment in Investment in Investment in Investment in
Type of non-current investments subsidiaries equity subsidiaries equity subsidiaries equity subsidiaries equity
instruments instruments instruments instruments
Class of non-current investments Trade investments Trade investments Trade investments Trade investments
Unquoted Equity Unquoted Equity Unquoted Equity Unquoted Equity
Nature of non-current investments Instruments Instruments Instruments Instruments
Non-current investments 149,94,51,300 126,94,51,310 23,00,00,000 23,00,00,000
Optival Health Optival Health Ritemed Pharma
Name of body corporate in whom investment has Ritemed Pharma
Solutions Private Solutions Private Retail Private
been made Retail Private Limited
Limited Limited Limited
Details of whether such body corporate is
subsidiary, associate, joint venture or Subsidiary Subsidiary Subsidiary Subsidiary
controlled special purpose entity
Details of non-current investments [Table] ..(2)

Classification of non-current investments [Axis] Column 3 Column 4
01/04/2015 01/04/2014 01/04/2015 01/04/2014
to to to to
31/03/2016 31/03/2015 31/03/2016 31/03/2015
Non-current investments [Abstract]
Disclosure of details of non-current investments
[Abstract]
Details of non-current investments [LineItems]
Investment in Investment in Investment in Investment in
Type of non-current investments subsidiaries equity subsidiaries equity subsidiaries equity subsidiaries equity
instruments instruments instruments instruments
Class of non-current investments Trade investments Trade investments Trade investments Trade investments
Unquoted Equity Unquoted Equity Unquoted Equity Unquoted Equity
Nature of non-current investments Instruments Instruments Instruments Instruments
Non-current investments 99,980 99,980 4,36,00,000 2,66,00,000
M H S PanIndia Pharma PanIndia Pharma
Name of body corporate in whom investment has MHS Pharmaceuticals
Pharmaceuticals Distributors Private Distributors Private
been made Private Limited
Private Limited Limited Limited
Details of whether such body corporate is
subsidiary, associate, joint venture or Subsidiary Subsidiary Subsidiary Subsidiary
controlled special purpose entity

31/03/2016 31/03/2015
Disclosure of notes on non-current investments explanatory [TextBlock]
Aggregate amount of quoted non-current investments 0 0
Market value of quoted non-current investments 0 0
Aggregate amount of unquoted non-current investments 177,31,51,280 152,61,51,290
Aggregate provision for diminution in value of non-current investments 0 0
101
[200600] Notes - Subclassification and notes on liabilities and assets
Subclassification of trade receivables [Table] ..(1)

Classification of assets based on security
Classification of assets based on security [Axis] Unsecured considered good [Member]
[Member]
31/03/2016 31/03/2015 31/03/2016 31/03/2015
Subclassification and notes on liabilities and assets
[Abstract]
Trade receivables notes [Abstract]
Trade receivables [Abstract]
Subclassification of trade receivables
[Abstract]
Subclassification of trade receivables
[LineItems]
Breakup of trade receivables [Abstract]
Trade receivables, gross 17,96,940 20,55,578 17,96,940 20,55,578
Allowance for bad and doubtful debts 0 0 0 0
Total trade receivables 17,96,940 20,55,578 17,96,940 20,55,578
Details of trade receivables due by
directors, other officers or others
[Abstract]
Trade receivables due by directors 0 0
Trade receivables due by other officers 0 0
Trade receivables due by others 0 0
Total trade receivables due by
directors, other officers or 0 0
others
Details of trade receivables due by
firms or companies in which any director
is partner or director [Abstract]
Trade receivables due by firms in
0 0
which any director is partner
Trade receivables due by private
companies in which any director 0 0
is director
Trade receivables due by private
companies in which any director 0 0
is member
Total trade receivables due by firms
or companies in which any director is 0 0
partner or director
Classification of inventories [Table] ..(1)

Classification of inventories [Axis] Company total inventories [Member] Stores and spares [Member]
01/04/2015 01/04/2014 01/04/2015 01/04/2014
to to to to
31/03/2016 31/03/2015 31/03/2016 31/03/2015
[Abstract]
Inventories notes [Abstract]
Inventories [Abstract]
Classification of inventories [Abstract]
Details of inventories [LineItems]
Inventories 13,01,792 9,93,670 13,01,792 9,93,670
Goods in transit 0 0 0 0
Mode of valuation NA NA NA NA
102
Disclosure of breakup of provisions [Table] ..(1)

Classification based on time period
[Member]
31/03/2016 31/03/2015 31/03/2016 31/03/2015
[Abstract]
Provisions notes [Abstract]
Disclosure of breakup of provisions [Abstract]
Disclosure of breakup of provisions [LineItems]
Provisions [Abstract]
Provisions for employee benefits
[Abstract]
Provision gratuity 6,16,085 10,97,338 4,06,601 9,52,862
Provision leave encashment 21,60,897 19,93,897
Total provisions for employee benefits 27,76,982 30,91,235 4,06,601 9,52,862
CSR expenditure provision 0 0 0 0
Total provisions 27,76,982 30,91,235 4,06,601 9,52,862
Disclosure of breakup of provisions [Table] ..(2)

Classification based on time period [Axis] Short-term [Member]
31/03/2016 31/03/2015
Subclassification and notes on liabilities and assets [Abstract]
Provisions notes [Abstract]
Disclosure of breakup of provisions [Abstract]
Disclosure of breakup of provisions [LineItems]
Provisions [Abstract]
Provisions for employee benefits [Abstract]
Provision gratuity 2,09,484 1,44,476
Provision leave encashment 21,60,897 19,93,897
Total provisions for employee benefits 23,70,381 21,38,373
CSR expenditure provision 0 0
Total provisions 23,70,381 21,38,373
103
Loans and advances [Table] ..(1)

Classification of loans and advances [Axis] Loans and advances [Member] Security deposits [Member]
Classification of assets based on security [Axis] Unsecured considered good [Member] Unsecured considered good [Member]
01/04/2015 01/04/2014
31/03/2016 31/03/2015 to to
31/03/2016 31/03/2015
[Abstract]
Loans and advances notes [Abstract]
Loans and advances [Abstract]
Disclosure of loans and advances [LineItems]
Loans and advances, gross 4,15,00,339 3,50,43,303 11,94,195 9,04,608
Allowance for bad and doubtful loans and
0 0 0 0
advances
Loans and advances 4,15,00,339 3,50,43,303 11,94,195 9,04,608
Nature of other loans and advances Deposits - others Deposits - others
Details of loans and advances due by
[Abstract]
Loans and advances due by directors 0 0 0 0
Loans and advances due by other officers 0 0 0 0
Loans and advances due by others 0 0 0 0
Total loans and advances due by
0 0 0 0
Details of loans and advances due by firms
or companies in which any director is
partner or director [Abstract]
Loans and advances due by firms in
0 0 0 0
Loans and advances due by private
companies in which any director is 0 0 0 0
director
member
Total loans and advances due
by firms or companies in which
0 0 0 0
any director is partner or
director
104

Classification of loans and advances [Axis] Other loans and advances [Member] Advance tax [Member]
01/04/2015 01/04/2014
31/03/2016 31/03/2015 to to
31/03/2016 31/03/2015
[Abstract]
Loans and advances, gross 4,03,06,144 3,41,38,695 4,02,07,420 3,40,77,296
0 0 0 0
advances
Loans and advances 4,03,06,144 3,41,38,695 4,02,07,420 3,40,77,296
Advance income tax Advance income tax
Nature of other loans and advances (including TDS (including TDS
receivable) receivable)
[Abstract]
0 0 0 0
0 0 0 0
director
member
0 0 0 0
director
105

Deposits with statutory authorities
Classification of loans and advances [Axis] Advance income tax paid [Member]
[Member]
01/04/2015 01/04/2014 01/04/2015 01/04/2014
to to to to
31/03/2016 31/03/2015 31/03/2016 31/03/2015
[Abstract]
Loans and advances, gross 4,02,07,420 3,40,77,296 98,724 61,399
0 0 0 0
advances
Loans and advances 4,02,07,420 3,40,77,296 98,724 61,399
Balances with
Advance income tax Advance income tax Balances with
statutory /
Nature of other loans and advances (including TDS (including TDS
government
statutory / government
receivable) receivable) authorities
authorities
[Abstract]
0 0 0 0
0 0 0 0
director
member
0 0 0 0
director
106

Loans and advances to related parties
Classification of loans and advances [Axis] Loans and advances [Member]
[Member]
31/03/2016 31/03/2015 31/03/2016 31/03/2015
[Abstract]
Loans and advances, gross 26,23,886 6,88,281 19,57,742 78,207
0 0 0 0
advances
Loans and advances 26,23,886 6,88,281 19,57,742 78,207
[Abstract]
0 0 0 0
0 0 0 0
director
member
0 0 0 0
director
107

Loans advances given other related Loans advances given employees
Classification of loans and advances [Axis]
parties [Member] [Member]
01/04/2015 01/04/2014 01/04/2015 01/04/2014
to to to to
31/03/2016 31/03/2015 31/03/2016 31/03/2015
[Abstract]
Loans and advances, gross 19,57,742 78,207 89,474 1,75,652
0 0 0 0
advances
Loans and advances 19,57,742 78,207 89,474 1,75,652
Loans and advances Loans and advances to Advances to Advances to
Nature of other loans and advances to related parties related parties employees employees
[Abstract]
0 0 0 0
0 0 0 0
director
member
0 0 0 0
director
108

Loans advances value be received
Classification of loans and advances [Axis] Other loans and advances [Member]
[Member]
01/04/2015 01/04/2014
to to 31/03/2016 31/03/2015
31/03/2016 31/03/2015
[Abstract]
Loans and advances, gross 3,01,353 86,993 2,75,317 3,47,429
0 0 0 0
advances
Loans and advances 3,01,353 86,993 2,75,317 3,47,429
Advances
Advances recoverable
recoverable in cash
Nature of other loans and advances or kind or for value
in cash or kind or for
value to be received
to be received
[Abstract]
0 0 0 0
0 0 0 0
director
member
0 0 0 0
director
109

Classification of loans and advances [Axis] Prepaid expenses [Member]
Classification of assets based on security [Axis] Unsecured considered good [Member]
01/04/2015 01/04/2014
to to
31/03/2016 31/03/2015
Subclassification and notes on liabilities and assets [Abstract]
Loans and advances, gross 2,75,317 3,47,429
Allowance for bad and doubtful loans and advances 0 0
Loans and advances 2,75,317 3,47,429
Nature of other loans and advances Prepaid expenses Prepaid expenses
Details of loans and advances due by directors, other officers or others
[Abstract]
Loans and advances due by directors 0 0
Loans and advances due by other officers 0 0
Loans and advances due by others 0 0
Total loans and advances due by directors, other officers or others 0 0
Details of loans and advances due by firms or companies in which any
director is partner or director [Abstract]
Loans and advances due by firms in which any director is partner 0 0
Loans and advances due by private companies in which any director is
0 0
director
Loans and advances due by private companies in which any director is member 0 0
Total loans and advances due by firms or companies in which any director
0 0
is partner or director
110

01/04/2015 01/04/2014
to to 31/03/2014
31/03/2016 31/03/2015
Disclosure of subclassification and notes on liabilities and assets
explanatory [TextBlock]
Trade payables, long-term 0 0
Others long-term, others (A) 19,79,26,906 (B) 5,24,44,825

Total others, long-term 19,79,26,906 5,24,44,825
Total other long-term liabilities 19,79,26,906 5,24,44,825
Interest accrued but not due on borrowings 0 0
Interest accrued and due on borrowings 0 0
Interest accrued but not due on public deposits 0 0
Interest accrued and due on public deposits 0 0
Debentures claimed but not paid 0 0
Unpaid dividends 0 0
Application money received for allotment of securities and
0 0
due for refund, principal
Unpaid matured deposits and interest accrued thereon 0 0
Unpaid matured debentures and interest accrued thereon 0 0
Public deposit payable, current 0 0
Advance received from customers 1,04,130 3,74,880
Current liabilities portion of share application money pending
0 0
allotment
Other current liabilities, others (C) 9,63,323 (D) 7,82,615
Total other current liabilities 10,67,453 11,57,495
Other non-current assets, others 75,000 75,000
Total other non-current assets 75,000 75,000
Nature of other non-current assets, others NA NA
Aggregate amount of trade receivables outstanding for period
0 0
exceeding six months
Fixed deposits with banks 0 0
Other balances with banks (E) 1,72,67,483 (F) 30,05,19,839

Total balance with banks 1,72,67,483 30,05,19,839
Cash on hand 1,84,670 2,39,224
Total cash and cash equivalents 1,74,52,153 30,07,59,063 2,66,178
Total cash and bank balances 1,74,52,153 30,07,59,063
Total balances held with banks to extent held as
margin money or security against borrowings, 0 0
guarantees or other commitments
Bank deposits with more than twelve months maturity 0 0
Other current assets, others (G) 1,12,052 (H) 5,51,605

Total other current assets 1,12,052 5,51,605
Footnotes
(A) Premium payable on redemption of non - convertible debentures (refer note a )Rs.154343512 Premium payable on redemption of
redeemable preference shares (refer note a ) Rs.43583394
(B) Premium payable on redemption of non - convertible debentures (refer note a )Rs.41022831 Premium payable on redemption of
redeemable preference shares (refer note a ) Rs.11421994
(C) statutory liabilities
(D) statutory liabilities
(E) Balances with scheduled banks - On current accounts Rs.2267483 - Deposits with original maturity of less than 3 months
Rs.15000000
(F) Balances with scheduled banks - On current accounts Rs.5999067 - Deposits with original maturity of less than 3 months
Rs.294520772
(G) Non-current bank balances (refer note no. 16) Rs.0.00 Interest accrued on fixed depositsRs.112052
(H) Non-current bank balances (refer note no. 16) Rs.0.00 Interest accrued on fixed depositsRs.551605
111
[200700] Notes - Additional disclosures on balance sheet

01/04/2015 01/04/2014
to to
31/03/2016 31/03/2015
Disclosure of additional balance sheet notes explanatory [TextBlock]
Total contingent liabilities and commitments 0 0
Amount of dividends proposed to be distributed to equity shareholders 0 0
Amount of per share dividend proposed to be distributed to equity
[INR/shares] 0 [INR/shares] 0
shareholders
Deposits accepted or renewed during period 0 0
Deposits matured and claimed but not paid during period 0 0
Deposits matured and claimed but not paid 0 0
Deposits matured but not claimed 0 0
Interest on deposits accrued and due but not paid 0 0
Share application money received during year 0 0
Share application money paid during year 0 0
Amount of share application money received back during year 0 0
Amount of share application money repaid returned back during year 0 0
Number of person share application money paid during year [pure] 0 [pure] 0
Number of person share application money received during year [pure] 0 [pure] 0
Number of person share application money paid as at end of year [pure] 0 [pure] 0
Number of person share application money received as at end of year [pure] 0 [pure] 0
Whether maintenance of cost records by company has been
mandated under Companies (Cost Records and Audit) Rules, No No
2014
Unclaimed share application refund money 0 0
Unclaimed matured debentures 0 0
Unclaimed matured deposits 0 0
Interest unclaimed amount 0 0
Number of warrants converted into equity shares during period [pure] 0 [pure] 0
Number of warrants converted into preference shares during period [pure] 0 [pure] 0
Number of warrants converted into debentures during period [pure] 0 [pure] 0
Number of warrants issued during period (in foreign currency) [pure] 0 [pure] 0
Number of warrants issued during period (INR) [pure] 0 [pure] 0
[200800] Notes - Disclosure of accounting policies, changes in accounting policies and estimates
01/04/2015
to
31/03/2016
Disclosure of accounting policies, change in accounting policies and Textual information (32)
changes in estimates explanatory [TextBlock] [See below]
112
Disclosure of accounting policies, change in accounting policies and changes in estimates explanatory [Text Block]
Corporate
1.
information
MedPlus Health Services Private Limited (the ‘Company’) was incorporated on November
13, 2006 and is a company registered under Indian Companies Act, 1956. The Company
has foreign direct investment of 49%. The Company is in the business of pathological
laboratory testing.
Basis of
2.
preparation
The financial statements of the company have been prepared in accordance with the
generally accepted accounting principles in India (Indian GAAP). The company has
prepared these financial statements to comply in all material respects with the accounting
standards notified under section 133 of the Companies Act 2013, read together with
paragraph 7 of the Companies (Accounts) Rules 2014. The accounting policies adopted in
the preparation of financial statements are consistent with those of previous year.
Summary
of
2.1. significant
accounting
policies
(a) Use of estimates
The preparation of financial statements in conformity with Indian GAAP requires the
management to make judgments, estimates and assumptions that affect the reported
amounts of revenues, expenses, assets and liabilities and the disclosure of contingent
liabilities, at the end of the reporting period. Although these estimates are based on the
management’s best knowledge of current events and actions, uncertainty about these
assumptions and estimates could result in the outcomes requiring a material adjustment to
the carrying amounts of assets or liabilities in future periods.
(b) Tangible fixed assets
Fixed assets are stated at cost, less accumulated depreciation and impairment losses, if
any. The cost comprises purchase price and directly attributable cost of bringing the asset
to its working condition for the intended use. Any trade discounts and rebates are deducted
in arriving at the purchase price.
Subsequent expenditure related to an item of fixed asset is added to its book value only if it
increases the future benefits from the existing asset beyond its previously assessed
standard of performance. All other expenses on existing fixed assets, including day-to-day
repair and maintenance expenditure and cost of replacing parts, are charged to the
statement of profit and loss for the period during which such expenses are incurred.
Gains or losses arising from derecognition of fixed assets are measured as the difference
between the net disposal proceeds and the carrying amount of the asset and recognized in
the statement of profit and loss when the asset is derecognized.
(c) Depreciation on tangible fixed assets
Depreciation on fixed assets other than leasehold improvements is calculated on a

straight-line basis using the rates arrived at based on the useful lives estimated by the
management which coincide with the lives prescribed under the schedule II to the
Depreciation on leasehold improvements is provided over the lease term or 5 years,

whichever is shorter, which is higher than the rates prescribed under the schedule II to the
113
(d) Intangible assets
Intangible assets acquired separately are measured on initial recognition at cost. Following
initial recognition, intangible assets are carried at cost less accumulated amortization and
accumulated impairment losses, if any.
Intangible assets are amortized on a straight line basis over a period of five years or
estimated useful life whichever is lower.
(e) Impairment of tangible assets and intangible assets
The Company assesses at each reporting date whether there is an indication that an asset
may be impaired. If any indication exists, or when annual impairment testing for an asset is
required, the Company estimates the asset’s recoverable amount. An asset’s recoverable
amount is the higher of an asset’s net selling price and its value in use. The recoverable
amount is determined for an individual asset, unless the asset does not generate cash
inflows that are largely independent of those from other assets or groups of assets. Where
the carrying amount of an asset exceeds its recoverable amount, the asset is considered
impaired and is written down to its recoverable amount. In assessing value in use, the
estimated future cash flows are discounted to their present value using a pre-tax discount
rate that reflects current market assessments of the time value of money and the risks
specific to the asset. In determining net selling price, recent market transactions are taken
into account, if available. If no such transactions can be identified, an appropriate valuation
model is used.
Impairment losses, including impairment on inventories, are recognized in the statement of

profit and loss.
After impairment, depreciation is provided on the revised carrying amount of the asset over
its remaining useful life.
An assessment is made at each reporting date as to whether there is any indication that
previously recognized impairment losses may no longer exist or may have decreased. If
such indication exists, the company estimates the asset’s or cash-generating unit’s
recoverable amount. A previously recognized impairment loss is reversed only if there has
been a change in the assumptions used to determine the asset’s recoverable amount since
the last impairment loss was recognized. The reversal is limited so that the carrying amount
of the asset does not exceed its recoverable amount, nor exceed the carrying amount that
would have been determined, net of depreciation, had no impairment loss been recognized
for the asset in prior years. Such reversal is recognized in the statement of profit and loss
unless the asset is carried at a revalued amount, in which case the reversal is treated as a
revaluation increase.
(f) Leases
Leases, where the lessor effectively retains substantially all the risks and benefits of
ownership of the leased item, are classified as operating leases. Operating lease payments
are recognized as an expense in the statement of profit and loss on a straight-line basis
over the lease term.
(g) Investments
Investments, which are readily realizable and intended to be held for not more than one
year from the date on which such investments are made, are classified as current
investments. All other investments are classified as long-term investments.
On initial recognition, all investments are measured at cost. The cost comprises purchase
price and directly attributable acquisition charges such as brokerage, fees and duties. If an
investment is acquired, or partly acquired, by the issue of shares or other securities, the
acquisition cost is the fair value of the securities issued. If an investment is acquired in
exchange for another asset, the acquisition is determined by reference to the fair value of
the asset given up or by reference to the fair value of the investment acquired, whichever is
more clearly evident.
Current investments are carried in the financial statements at lower of cost and fair value
determined on an individual investment basis. Long-term investments are carried at cost.
114
However, provision for diminution in value is made to recognize a decline other than
temporary in the value of the investments.
On disposal of an investment, the difference between its carrying amount and net disposal
proceeds is charged or credited to the statement of profit and loss.
(h) Inventories
Inventories comprise of stores and spares and are valued at lower of cost and net
realizable value. Cost is determined on first in first out basis. Net realizable value is the
estimated selling price in the ordinary course of business reduced by the estimated costs to
affect the sale.
(i) Revenue recognition
Revenue is recognized to the extent that it is probable that the economic benefits will flow
to the Company and the revenue can be reliably measured. The following specific
recognition criteria must also be met before revenue is recognized:
Income from services
Revenue from pathological laboratory services and running of clinics are recognised as and
when services are rendered.
Interest
Interest is recognized on a time proportion basis taking into account the amount
outstanding and the rate applicable.
(j) Foreign currency translation
Initial recognition
Foreign currency transactions are recorded in the reporting currency, by applying to the
foreign currency amount the exchange rate between the reporting currency and the foreign
currency at the date of the transaction.
Conversion
Foreign currency monetary items are retranslated using the exchange rate prevailing at the
reporting date. Non-monetary items, which are measured in terms of historical cost
denominated in a foreign currency, are reported using the exchange rate at the date of the
transaction. Non-monetary items, which are measured at fair value or other similar
valuation denominated in a foreign currency, are translated using the exchange rate at the
date when such value was determined.
Exchange differences
Exchange differences arising on settlement of monetary items or on reporting such

monetary items of the Company at rates different from those at which they were initially
recorded during the year, or reported in previous financial statements, are recognised as
income or as expenses in the year in which they arise.
(k) Retirement and other employee benefits
Retirement benefit in the form of provident fund is a defined contribution scheme. The
contributions to the provident fund are charged to the statement of profit and loss for the
year when the contributions are due. The Company has no obligation, other than the
contribution payable to the provident fund.
The Company operates a defined benefit plan for its employees, viz., gratuity. The costs of
providing benefits under the plan are determined on the basis of actuarial valuation at each
year-end using the projected unit credit method. Actuarial gains and losses for the defined
benefit plan are recognized in full in the period in which they occur in the statement of profit
and loss.
Accumulated leave, which is expected to be utilized within the next 12 months, is treated as
short-term employee benefit. The Company measures the expected cost of such absences
as the additional amount that it expects to pay as a result of the unused entitlement that
115
has accumulated at the reporting date.
The Company treats accumulated leave expected to be carried forward beyond twelve
months, as long-term employee benefit for measurement purposes. Such long-term
compensated absences are provided for based on the actuarial valuation using the
projected unit credit method at the year-end. Actuarial gains/losses are immediately taken
to the statement of profit and loss and are not deferred. The company presents the entire
leave as a current liability in the balance sheet, since it does not have an unconditional right
to defer its settlement for 12 months after the reporting date.
(l) Employee stock compensation cost
Employees (including senior executives) of the company receive remuneration in the form
of share based payment transactions, whereby employees render services as consideration
for equity instruments.
In accordance with the Guidance Note on Accounting for Employee Share-based

Payments, the cost of equity-settled transactions is measured using the intrinsic value
method and recognized, together with a corresponding increase in the “Stock options
outstanding account” in reserves. The cumulative expense recognized for equity-settled
transactions at each reporting date until the vesting date reflects the extent to which the
vesting period has expired and the company’s best estimate of the number of equity
instruments that will ultimately vest. The expense or credit recognized in the statement of
profit and loss for a period represents the movement in cumulative expense recognized as
at the beginning and end of that period and is recognized in employee benefit expenses.
(m) Income taxes
Tax expense comprises current and deferred tax. Current income-tax is measured at the
amount expected to be paid to the tax authorities in accordance with the Income-tax Act,
1961 enacted in India. The tax rates and tax laws used to compute the amounts are those
that are enacted or substantively enacted, at the reporting date.
Deferred income taxes reflects the impact of timing differences between taxable income
and accounting income originating during the current year and reversal of timing differences
for the earlier years. Deferred tax is measured using the tax rates and the tax laws enacted
or substantively enacted at the reporting date.
Deferred tax liabilities are recognized for all taxable timing differences. Deferred tax assets
are recognized for deductible timing differences only to the extent that there is reasonable
certainty that sufficient future taxable income will be available against which such deferred
tax assets can be realized. In situations where the company has unabsorbed depreciation
or carry forward tax losses, all deferred tax assets are recognized only if there is virtual
certainty supported by convincing evidence that they can be realized against future taxable
profits.
At each reporting date, the company re-assesses unrecognized deferred tax assets. It
recognizes unrecognized deferred tax asset to the extent that it has become reasonably
certain or virtually certain, as the case may be, that sufficient future taxable income will be
available against which such deferred tax assets can be realized.
(n) Earnings per share
Basic earnings per share are calculated by dividing the net profit or loss for the period
attributable to equity shareholders by the weighted average number of equity shares
outstanding during the period.
For the purpose of calculating diluted earnings per share, the net profit or loss for the period
attributable to equity shareholders and the weighted average number of shares outstanding
during the period are adjusted for the effects of all dilutive potential equity shares.
(o) Provisions
A provision is recognized when the company has a present obligation as a result of past
event, it is probable that an outflow of resources embodying economic benefits will be
required to settle the obligation and a reliable estimate can be made of the amount of the
116
obligation. Provisions are not discounted to their present value and are determined based
on the best estimate required to settle the obligation at the reporting date. These estimates
are reviewed at each reporting date and adjusted to reflect the current best estimates.
(p) Contingent liabilities
A contingent liability is a possible obligation that arises from past events whose existence
will be confirmed by the occurrence or non-occurrence of one or more uncertain future
events beyond the control of the company or a present obligation that is not recognized
because it is not probable that an outflow of resources will be required to settle the
obligation. A contingent liability also arises in extremely rare cases where there is a liability
that cannot be recognized because it cannot be measured reliably. The company does not
recognize a contingent liability but discloses its existence in the financial statements.
(q) Cash and cash equivalents
Cash and cash equivalents for the purposes of cash flow statement comprise cash at bank
and in hand and short-term investments with an original maturity of three months or less.
[201700] Notes - Government grants

01/04/2015 01/04/2014
to to
31/03/2016 31/03/2015
Disclosure of notes on government grants explanatory [TextBlock]
Capital subsidies or grants received from government authorities 0 0
Revenue subsidies or grants received from government authorities 0 0
[201200] Notes - Employee benefits

01/04/2015
to
31/03/2016
Disclosure of employee benefits explanatory [TextBlock] [See below]
117
Disclosure of employee benefits explanatory [Text Block]

Employee
19. benefits
expense
March 31, March 31,

2016 2015
Salaries, wages and bonus [net of

reimbursement of Rs.20,151,185
12,795,649 12,382,571
(March 31, 2015: Rs.18,310,330)]
Contribution to provident fund

1,098,797 907,490
Gratuity expense (refer note no.

24) 275,747 591,999
Staff welfare expenses [net of

reimbursement of
Rs.96,098(March 31, 2015: 667,081 493,920
Rs.79,447)]
Amortisation of employees stock

compensation expenses 13,061,452 13,258,815
27,898,726 27,634,795
118
[201600] Notes - Related party
Disclosure of relationship and transactions between related parties [Table] ..(1)

Categories of related parties [Axis] Column 1 Column 2
01/04/2015 01/04/2014 01/04/2015 01/04/2014
to to to to
31/03/2016 31/03/2015 31/03/2016 31/03/2015
Disclosure of relationship and transactions
between
related parties [Abstract]
Disclosure of relationship and
transactions between
related parties [LineItems]
OPTIVAL HEALTH OPTIVAL HEALTH RITEMED PHARMA RITEMED PHARMA
Name of related party SOLUTIONS PRIVATE SOLUTIONS PRIVATE RETAIL PRIVATE RETAIL PRIVATE
LIMITED LIMITED LIMITED LIMITED
Country of incorporation or residence
of related India India India India
party
CIN of related party U85110TG2005PTC046821 U85110TG2005PTC046821 U52399TG2009PTC064130 U52399TG2009PTC064130
Description of nature of related party
Subsidiary company Subsidiary company Subsidiary company Subsidiary company
relationship
Description of nature of transactions
with related Multiple Transactions Multiple Transactions Multiple Transactions Multiple Transactions
party
Related party transactions [Abstract]
Purchases of tangible assets related
party 4,63,946 0
transactions
Revenue from rendering of services
related 1,64,70,852 1,50,25,344 37,76,671 37,76,671
party transactions
Advances given during year related
party 0 3,00,00,000
transactions
Advances taken during year related
party 0 3,00,00,000
transactions
Interest paid during year related party
0 8,82,739
transactions
Reimbursement of expenses incurred
on
behalf of company during year 0 3,429
related
party transactions
Reimbursement of expenses incurred
by
related party during year related party 3,72,254 3,32,593 10,504 13,519
transactions
Transfers under finance agreements
related
party transactions [Abstract]
Equity contributions made under
finance
23,00,00,000 8,00,00,000
agreements related party
transactions
Provision of guarantees or collateral
to 105,00,00,000 75,00,00,000 18,00,00,000 18,00,00,000
enterprise related party transactions
Other related party transactions
9,23,990 8,15,839 86,339 68,649
expense
3,25,523 5,69,692
income
119

contribution 0 1,57,693
made
Amount written off during period in
respect 0 0 0 0
of debts due from related parties
Amount written back during period in
respect 0 0 0 0
of debts due to related parties

01/04/2015 01/04/2014 01/04/2015 01/04/2014
to to to to
31/03/2016 31/03/2015 31/03/2016 31/03/2015
Disclosure of relationship and transactions
between
Disclosure of relationship and
transactions between
M H S M H S PANINDIA PHARMA PANINDIA PHARMA
Name of related party PHARMACEUTICALS PHARMACEUTICALS DISTRIBUTORS DISTRIBUTORS
PRIVATE LIMITED PRIVATE LIMITED PRIVATE LIMITED PRIVATE LIMITED
of related India India India India
party
CIN of related party U24233TG2008PTC059624 U24233TG2008PTC059624 U24232TG2007PTC055895 U24232TG2007PTC055895
Description of nature of related party
Subsidiary company Subsidiary company Subsidiary company Subsidiary company
relationship
Description of nature of transactions
with related Multiple Transactions Multiple Transactions Multiple Transactions Multiple Transactions
party
Revenue from rendering of services
related 3,39,186 3,02,607
party transactions
Transfers under finance agreements
related
Equity contributions made under
finance
1,70,00,000 1,00,00,000
agreements related party
transactions
Amount written off during period in
respect 0 0 0 0
Amount written back during period in
respect 0 0 0 0
120

01/04/2015 01/04/2014 01/04/2015 01/04/2014
to to to to
31/03/2016 31/03/2015 31/03/2016 31/03/2015
Disclosure of relationship and transactions between
MEDSUPPLY MEDSUPPLY
G Madhukar
Name of related party DISTRIBUTORS DISTRIBUTORS
Reddy
G Madhukar Reddy
PRIVATE LIMITED PRIVATE LIMITED
Country of incorporation or residence of related
party
Permanent account number of related party AJEPG8481E AJEPG8481E
CIN of related party U24239TG2007PTC052676 U24239TG2007PTC052676
Key Management Key Management
Description of nature of related party relationship Subsidiary company Subsidiary company
Personnel Personnel
Description of nature of transactions with related
Multiple Transactions Multiple Transactions Remuneration Remuneration
party
Revenue from rendering of services related
0 14,532
party transactions
Reimbursement of expenses incurred by
related party during year related party 7,66,708 12,61,607
transactions
Transfers under finance agreements related
Equity contributions made under finance
agreements related party transactions, 0.00% 35000000.00%
percentage
Other related party transactions expense 0 59,529
Transaction relating to key management personnel
[Abstract]
Remuneration for key managerial personnel 40,00,000 40,00,000
Amount written off during period in respect
0 0 0 0
Amount written back during period in respect
0 0 0 0
121

01/04/2015 01/04/2014 01/04/2015 01/04/2014
to to to to
31/03/2016 31/03/2015 31/03/2016 31/03/2015
IL & FS Trust IL & FS Trust
Company Limited Company Limited (As
Name of related party C Bhaskar Reddy C Bhaskar Reddy (As trustee of India trustee of India
Venture Trust - Venture Trust - Fund-
Fund- I) I)
party
Permanent account number of related party AFKPC5689Q AFKPC5689Q
AAATI6554P AAATI6554P
Enterprises which
Enterprises which are
are owned, or have
owned, or have
significant influence
Key Management Key Management of or are partners
Description of nature of related party relationship Personnel Personnel with Key
of or are partners with
Key management
management
personnel and their
personnel and their
relatives
relatives
Description of nature of transactions with related Multiple
Remuneration Remuneration Multiple Transactions
party Transactions
0 47,86,866
transactions
Other related party transactions contribution
0 4,00,00,000
made
Transaction relating to key management personnel
[Abstract]
Remuneration for key managerial personnel 53,36,100 48,51,000
0 0 0 0
0 0 0 0
122

01/04/2015 01/04/2014 01/04/2015 01/04/2014
to to to to
31/03/2016 31/03/2015 31/03/2016 31/03/2015
IL & FS Trust IL & FS Trust IL & FS Trust
IL & FS Trust
Company Limited Company Limited Company Limited (As
Company Limited (As
Name of related party (As trustee of TVS
trustee of TVS Sriram
(As trustee of India trustee of India
Sriram Growth Fund Venture Trust - Venture Trust - Fund-
Growth Fund I)
I) Fund- II) II)
party
Permanent account number of related party AABTT5582H AABTT5582H AABTI1118C AABTI1118C
Enterprises which Enterprises which
Enterprises which are Enterprises which are
are owned, or have are owned, or have
owned, or have owned, or have
significant influence significant influence
significant influence significant influence
of or are partners of or are partners
Description of nature of related party relationship with Key
with Key
Key management Key management
management management
personnel and their personnel and their
personnel and their personnel and their
relatives relatives
relatives relatives
Description of nature of transactions with related Multiple Multiple
Multiple Transactions Multiple Transactions
party Transactions Transactions
0 47,86,866
transactions
Other related party transactions contribution
0 4,00,00,000 0 4,00,00,000
made
0 0 0 0
0 0 0 0

Categories of related parties [Axis] Column 11
01/04/2015 01/04/2014
to to
31/03/2016 31/03/2015
Disclosure of relationship and transactions between related parties [Abstract]
Disclosure of relationship and transactions between related parties [LineItems]
MKCP Institutional MKCP Institutional
Name of related party Inve s tor s Inve s tor s
(Mauritius) III Ltd (Mauritius) III Ltd
Country of incorporation or residence of related party MAURITIUS MAURITIUS
Enterprises which
Enterprises which are
are owned, or have
owned, or have
of or are partners
Description of nature of related party relationship with Key
Key management
management
personnel and their
personnel and their
relatives
relatives
Multiple
Description of nature of transactions with related party Transactions
Multiple Transactions

Interest paid during year related party transactions 428 0
Other related party transactions contribution made 0 42,84,70,000
Amount written off during period in respect of debts due from related parties 0 0
Amount written back during period in respect of debts due to related parties 0 0
123

01/04/2015 01/04/2014
to to
31/03/2016 31/03/2015
Disclosure of notes on related party explanatory [TextBlock]
Whether there are any related party transactions during year Yes Yes
Whether company is subsidiary company No No
[201400] Notes - Leases

01/04/2015 01/04/2014
to to
31/03/2016 31/03/2015
Disclosure of leases explanatory [TextBlock]
Whether any operating lease has been converted to financial lease or
No No
vice-versa
[300300] Notes - Earnings per share

01/04/2015 01/04/2014
to to
31/03/2016 31/03/2015
Disclosure of earnings per share explanatory [TextBlock]
Adjustments of numerator to calculate basic earnings per share [Abstract]
Adjustments of numerator to calculate diluted earnings per share [Abstract]
124
[202800] Notes - Subsidiary information
Details of subsidiaries [Table] ..(1)

Subsidiaries [Axis] Column 1 Column 2 Column 3 Column 4
01/04/2015 01/04/2015 01/04/2015 01/04/2015
to to to to
31/03/2016 31/03/2016 31/03/2016 31/03/2016
Details of subsidiaries [Abstract]
Details of subsidiaries [LineItems]
OPTIVAL HEALTH RITEMED PHARMA M H S PANINDIA PHARMA
Name of subsidiary SOLUTIONS PRIVATE RETAIL PRIVATE PHARMACEUTICALS DISTRIBUTORS
LIMITED LIMITED PRIVATE LIMITED PRIVATE LIMITED
INDIA INDIA INDIA INDIA
of subsidiary
CIN of subsidiary company U85110TG2005PTC046821 U52399TG2009PTC064130 U24233TG2008PTC059624 U24232TG2007PTC055895
Nature of issuing authority in country
of Ministry of Corporate Ministry of Corporate Ministry of Corporate Ministry of Corporate
incorporation or residence subsidiary Affairs Affairs Affairs Affairs
company
Section under which company became
Section 2(87)(ii) Section 2(87)(ii) Section 2(87)(ii) Section 2(87)(ii)
subsidiary
Whether subsidiary has filed balance
Yes Yes Yes Yes
sheet
SRN of filing of balance sheet by
G25094848 G25684176 G24282782 G25096496
subsidiary
Whether financial year of subsidiary
different from financial year of holding
No No No No
company
Financial year of subsidiary [Abstract]
Start date of accounting period of
01/04/2015 01/04/2015 01/04/2015 01/04/2015
subsidiary
End date of accounting period of
31/03/2016 31/03/2016 31/03/2016 31/03/2016
subsidiary
Percentage of shareholding in
99.98% 100.00% 99.98% 100.00%
subsidiary
Key information about subsidiary
[Abstract]
Reporting currency of subsidiary INR INR INR INR
Exchange rate as applicable for
NA NA NA NA
subsidiary
Share capital of subsidiary 141,54,40,000 23,00,00,000 1,00,000 4,36,00,000
Reserves and surplus of subsidiary -8,81,20,000 6,61,30,000 2,85,00,000 -43,10,000
Total assets of subsidiary 396,54,40,000 75,09,50,000 11,49,10,000 3,95,60,000
Total liabilities of subsidiary 396,54,40,000 75,09,50,000 11,49,10,000 3,95,60,000
Investment of subsidiary 0 4,10,000 0 3,86,50,000
Turnover of subsidiary 1,660,26,80,000 433,12,80,000 36,34,80,000 0
Profit before tax of subsidiary 10,85,50,000 8,70,30,000 2,35,50,000 -1,00,000
Provision for tax of subsidiary 2,00,70,000 43,20,000 16,40,000 20,000
Profit after tax of subsidiary 5,90,90,000 5,85,70,000 1,53,30,000 -1,40,000
Proposed dividend of subsidiary 0 0 0 0
125

Subsidiaries [Axis] Column 5 Column 6 Column 7 Column 8
01/04/2015 01/04/2015 01/04/2015 01/04/2015
to to to to
31/03/2016 31/03/2016 31/03/2016 31/03/2016
MEDSUPPLY VENKATA KRISHNA
RITECURE PHARMA DECCAN MEDISALES
Name of subsidiary PRIVATE LIMITED
DISTRIBUTORS ENTERPRISES PRIVATE
PRIVATE LIMITED
PRIVATE LIMITED LIMITED
INDIA INDIA INDIA INDIA
of subsidiary
CIN of subsidiary company U24232TG2008PTC058385 U24239TG2007PTC052676 U51909TG2010PTC071012 U51397KA2011PTC059204
Nature of issuing authority in country
of Ministry of Corporate Ministry of Corporate Ministry of Corporate Ministry of Corporate
incorporation or residence subsidiary Affairs Affairs Affairs Affairs
company
Section under which company became
Section 2(87)(ii) Section 2(87)(ii) Section 2(87)(ii) Section 2(87)(ii)
subsidiary
Whether subsidiary has filed balance
Yes Yes Yes Yes
sheet
SRN of filing of balance sheet by
G25097429 G24308918 G24313280 G24268872
subsidiary
Whether financial year of subsidiary
different from financial year of holding
No No No No
company
Start date of accounting period of
01/04/2015 01/04/2015 01/04/2015 01/04/2015
subsidiary
End date of accounting period of
31/03/2016 31/03/2016 31/03/2016 31/03/2016
subsidiary
Percentage of shareholding in
100.00% 100.00% 100.00% 100.00%
subsidiary
Key information about subsidiary
[Abstract]
Reporting currency of subsidiary INR INR INR INR
Exchange rate as applicable for
NA NA NA NA
subsidiary
Share capital of subsidiary 1,00,000 12,57,70,000 1,80,000 21,00,000
Reserves and surplus of subsidiary -8,30,000 -12,34,30,000 1,90,10,000 98,20,000
Total assets of subsidiary 51,000 27,60,000 4,08,30,000 4,45,10,000
Total liabilities of subsidiary 51,000 27,60,000 4,08,30,000 4,45,10,000
Investment of subsidiary 0 0 0 0
Turnover of subsidiary 0 0 140,79,00,000 76,90,60,000
Profit before tax of subsidiary -34,000 -6,20,000 1,01,40,000 74,70,000
Provision for tax of subsidiary 0 0 14,60,000 6,00,000
Profit after tax of subsidiary -34,000 -1,51,20,000 66,40,000 50,90,000
Proposed dividend of subsidiary 0 0 0 0
126

Subsidiaries [Axis] Column 9 Column 10 Column 11
01/04/2015 01/04/2015 01/04/2015
to to to
31/03/2016 31/03/2016 31/03/2016
SHRI BANASHANKARI SIDSON PHARMA
SAI SRIDHAR PHARMA
Name of subsidiary PRIVATE LIMITED
PHARMA PRIVATE DISTRIBUTORS
LIMITED PRIVATE LIMITED
Country of incorporation or residence of subsidiary INDIA INDIA INDIA
CIN of subsidiary company U24232TG2007PTC055902 U74900KA2014PTC074302 U74900TG2014PTC092145
Nature of issuing authority in country of incorporation or Ministry of Corporate Ministry of Corporate Ministry of Corporate
residence subsidiary company Affairs Affairs Affairs
Section under which company became subsidiary Section 2(87)(ii) Section 2(87)(ii) Section 2(87)(ii)
Whether subsidiary has filed balance sheet Yes Yes No
SRN of filing of balance sheet by subsidiary G24310641 G24266439
Reason if no filing has been made by subsidiary Inadvertent Delay
Whether financial year of subsidiary different from financial
No No No
year of holding company
Start date of accounting period of subsidiary 01/04/2015 01/04/2015 01/04/2015
End date of accounting period of subsidiary 31/03/2016 31/03/2016 31/03/2016
Percentage of shareholding in subsidiary 100.00% 100.00% 99.99%
Key information about subsidiary [Abstract]
Reporting currency of subsidiary INR INR INR
Exchange rate as applicable for subsidiary NA NA NA
Share capital of subsidiary 2,38,000 21,00,000 2,01,00,000
Reserves and surplus of subsidiary 2,13,50,000 -6,70,000 -1,65,90,000
Total assets of subsidiary 6,02,90,000 1,29,50,000 3,30,30,000
Total liabilities of subsidiary 6,02,90,000 1,29,50,000 3,30,30,000
Investment of subsidiary 0 0 0
Turnover of subsidiary 113,21,10,000 13,66,40,000 21,98,80,000
Profit before tax of subsidiary 1,16,40,000 -2,000 -96,20,000
Provision for tax of subsidiary 11,00,000 0 0
Profit after tax of subsidiary 75,20,000 -2,000 -96,20,000
Proposed dividend of subsidiary 0 0 0

01/04/2015
to
31/03/2016
Disclosure of subsidiary information explanatory [TextBlock]
Whether company has subsidiary companies Yes
Number of subsidiary companies [pure] 11
Whether company has subsidiary companies which are yet to commence
No
operations
Whether company has subsidiary companies liquidated or sold during year No
[202400] Notes - Investments in associates

01/04/2015
to
31/03/2016
Disclosure of notes on investment in associates explanatory [TextBlock]
Whether company has invested in associates No
Whether company has associates which are yet to commence operations No
Whether company has associates liquidated or sold during year No
127
[202500] Notes - Financial reporting of interests in joint ventures

01/04/2015
to
31/03/2016
Disclosure of notes on interests in joint ventures explanatory [TextBlock]
Whether company has invested in joint ventures No
Whether company has joint ventures which are yet to commence operations No
Whether company has joint ventures liquidated or sold during year No
[202700] Notes - Cash flow statements

01/04/2015 01/04/2014
to to 31/03/2014
31/03/2016 31/03/2015
Disclosure of cash flow statement explanatory [TextBlock]
Cash and cash equivalents if different from balance sheet [Abstract]
Cash and cash equivalents cash flow statement 1,74,52,153 30,07,59,063 2,66,178
Total cash and cash equivalents 1,74,52,153 30,07,59,063 2,66,178
Income taxes paid (refund) [Abstract]
Income taxes paid (refund), classified as operating activities 61,30,124 2,82,65,763
Total income taxes paid (refund) 61,30,124 2,82,65,763
128
[100200] Statement of profit and loss

01/04/2015 01/04/2014
to to
31/03/2016 31/03/2015
Statement of profit and loss [Abstract]
Disclosure of revenue from operations [Abstract]
Disclosure of revenue from operations for other than finance company
[Abstract]
Revenue from sale of products 0 0
Revenue from sale of services 2,24,39,160 2,39,24,860
Total revenue from operations other than finance company 2,24,39,160 2,39,24,860
Total revenue from operations 2,24,39,160 2,39,24,860
Other income 1,00,61,274 1,24,52,079
Total revenue 3,25,00,434 3,63,76,939
Expenses [Abstract]
Cost of materials consumed 0 0
Changes in inventories of finished goods, work-in-progress and
0 0
stock-in-trade
Employee benefit expense 2,78,98,726 2,76,34,795
Finance costs 1,957 1,04,58,773
Depreciation, depletion and amortisation expense [Abstract]
Depreciation expense 28,55,139 29,47,811
Amortisation expense 0 0
Total depreciation, depletion and amortisation expense 28,55,139 29,47,811
CSR expenditure 0 0
Other expenses 4,47,80,371 2,91,72,514
Total expenses 7,55,36,193 7,02,13,893
Total profit before prior period items, exceptional items, extraordinary
-4,30,35,759 -3,38,36,954
items and tax
Exceptional items before tax 0
(A) -1,81,82,456
Total profit before extraordinary items and tax -4,30,35,759 -5,20,19,410
Total profit before tax -4,30,35,759 -5,20,19,410
Tax expense [Abstract]
Total tax expense 0 0
Total profit (loss) for period from continuing operations -4,30,35,759 -5,20,19,410
Total profit (loss) for period before minority interest -4,30,35,759 -5,20,19,410
Total profit (loss) for period -4,30,35,759 -5,20,19,410
Earnings per equity share [Abstract]
Basic earning per equity share [INR/shares] 0 [INR/shares] 0
Diluted earnings per equity share [INR/shares] 0 [INR/shares] 0
Footnotes
(A) - Provision for diminution in the value of investment
129
[300500] Notes - Subclassification and notes on income and expenses

01/04/2015 01/04/2014
to to
31/03/2016 31/03/2015
Subclassification and notes on income and expense explanatory [TextBlock]
Disclosure of revenue from sale of products [Abstract]
Revenue from sale of products [Abstract]
Total revenue from sale of products 0 0
Disclosure of revenue from sale of services [Abstract]
Revenue from sale of services [Abstract]
Revenue from sale of services, gross 2,24,39,160 2,39,24,860
Total revenue from sale of services 2,24,39,160 2,39,24,860
Disclosure of other income [Abstract]
Interest income [Abstract]
Total interest income 0 0
Dividend income [Abstract]
Total dividend income 0 0
Other non-operating income [Abstract]
Miscellaneous other non-operating income (A) 1,00,61,274 (B) 1,24,52,079
Total other non-operating income 1,00,61,274 1,24,52,079
Total other income 1,00,61,274 1,24,52,079
Disclosure of finance cost [Abstract]
Interest expense [Abstract]
Other interest charges (C) 1,957 (D) 1,04,58,773
Total interest expense 1,957 1,04,58,773
Total finance costs 1,957 1,04,58,773
Employee benefit expense [Abstract]
Salaries and wages 1,27,95,649 1,23,82,571
Managerial remuneration [Abstract]
Remuneration to directors [Abstract]
Total remuneration to directors 0 0
Total managerial remuneration 0 0
Contribution to provident and other funds [Abstract]
Contribution to provident and other funds for others 10,98,797 9,07,490
Total contribution to provident and other funds 10,98,797 9,07,490
Gratuity 2,75,747 5,91,999
Staff welfare expense 6,67,081 4,93,920
Other employee related expenses (E) 1,30,61,452 (F) 1,32,58,815

Total employee benefit expense 2,78,98,726 2,76,34,795
Breakup of other expenses [Abstract]
Consumption of stores and spare parts 82,90,271 88,96,746
Power and fuel 0 0
Rent 26,13,254 21,15,708
Repairs to building 0 0
Repairs to machinery 8,86,716 7,19,635
Insurance 1,32,074 1,20,770
Rates and taxes excluding taxes on income [Abstract]
Other cess taxes (G) 1,90,870 (H) 8,80,584
Total rates and taxes excluding taxes on income 1,90,870 8,80,584
Electricity expenses 10,58,096 13,07,826
Telephone postage 5,97,844 5,04,215
Printing stationery 3,79,719 4,48,153
Travelling conveyance 15,69,009 15,33,905
Legal professional charges 2,24,74,797 90,17,118
Directors sitting fees 0 0
Advertising promotional expenses 18,55,752 5,020
Provision bad doubtful debts created 4,04,293 1,83,639
130
Provision bad doubtful loans advances created 0 0

Write-off assets [Abstract]
Miscellaneous expenditure written off [Abstract]
Total miscellaneous expenditure written off 0 0
Bad debts written off 0 0
Bad debts advances written off 11,482 0
Total write-off assets 11,482 0
Loss on disposal of intangible asset 0 0
Loss on disposal, discard, demolishment and destruction of depreciable
4,951 72,247
tangible asset
Payments to auditor [Abstract]
Payment for audit services 7,19,548 5,79,572
Total payments to auditor 7,19,548 5,79,572
Miscellaneous expenses 35,91,695 27,87,376
Total other expenses 4,47,80,371 2,91,72,514
Footnotes
(A) bank deposits Rs.8403972 others Rs.315209 Rental income Rs.325523 Liabilities/provisions no longer required written back
Rs.614043 Miscellaneous income Rs.402527
(B) bank deposits Rs.11266226 others Rs.59529 Rental income Rs.569692 Liabilities/provisions no longer required written back
Rs.112004 Miscellaneous income Rs.444628
(C) Interest Rs.430 Bank charges Rs.1527
(D) Interest Rs.10456641 Bank charges Rs.2132
(E) Amortisation of employees stock compensation expenses
(F) Amortisation of employees stock compensation expenses
(G) rates and taxes
(H) rates and taxes
[300600] Notes - Additional information statement of profit and loss

01/04/2015 01/04/2014
to to
31/03/2016 31/03/2015
Additional information on profit and loss account explanatory [TextBlock]
Total changes in inventories of finished goods, work-in-progress and
0 0
stock-in-trade
Exceptional items before tax 0
(A) -1,81,82,456
Total exceptional items 0 -1,81,82,456
Total exceptional and extraordinary items 0 -1,81,82,456
Revenue domestic contracts 2,24,39,160 2,39,24,860
Total revenue contracts 2,24,39,160 2,39,24,860
Total gross income from services rendered 2,24,39,160 2,39,24,860
Expenditure on dividend paid 0 0
Total expenditure in foreign currency 0 0
Total amount of dividend remitted in foreign currency 0 0
Total earnings in foreign currency 0 0
Total revenue from sale of products 0 0
Domestic revenue services 2,24,39,160 2,39,24,860
Total revenue from sale of services 2,24,39,160 2,39,24,860
Gross value of transaction with related parties as per AS-18 0 0
Bad debts of related parties as per AS-18 0 0
Footnotes
(A) - Provision for diminution in the value of investment
131
[300100] Notes - Revenue

01/04/2015
to
31/03/2016
Disclosure of revenue explanatory [TextBlock] [See below]
Disclosure of revenue explanatory [Text Block]

Revenue from
17.
operations
March 31, March 31,

2016 2015
Sale of services
22,439,160 23,924,860
Net revenue from

operations 22,439,160 23,924,860
Details of service
rendered
March 31, March 31,

2016 2016
Pathological testing
services 22,074,124 23,614,206
Diagnostic Income
365,036 310,654
22,439,160 23,924,860
132
[300700] Notes - Key managerial personnels and directors remuneration and other information
Disclosure of key managerial personnels and directors and remuneration to key managerial personnels and directors [Table] ..(1)
Key managerial personnels and directors [Axis] Column 1 Column 2
01/04/2015 01/04/2015
to to
31/03/2016 31/03/2016
Disclosure of key managerial personnels and directors and remuneration to key
managerial personnels and directors [Abstract]
Disclosure of key managerial personnels and directors and remuneration to key
managerial personnels and directors [LineItems]
GANGADI
CHERUKUPALLI
Name of key managerial personnel or director MADHUKAR
BHASKAR REDDY
REDDY
Director identification number of key managerial personnel or director 00098097 00926550
Date of birth of key managerial personnel or director 20/09/1967 13/06/1968
Designation of key managerial personnel or director Managing Director Director
MBBS from
Kurnool Medical MS (General
Qualification of key managerial personnel or director College and a MBA Surgeon), FRCS
from the Wharton (Edinburgh).
School of Business
Shares held by key managerial personnel or director [shares] 33,280 [shares] 0
Key managerial personnel or director remuneration [Abstract]
Gross salary to key managerial personnel or director [Abstract]
Salary key managerial personnel or director 40,00,000 53,36,100
Perquisites key managerial personnel or director 0 0
Profits in lieu of salary key managerial personnel or director 0 0
Gross salary to key managerial personnel or director 40,00,000 53,36,100
Sitting fees key managerial personnel or director 0 0
Stock option key managerial personnel or director 0 0
Sweat equity key managerial personnel or director 0 0
Commission as percentage of profit key managerial personnel or director 0 0
Other commission key managerial personnel or director 0 0
Other compensation key managerial personnel or director 0 0
Total key managerial personnel or director remuneration 40,00,000 53,36,100
[301000] Notes - Corporate social responsibility

01/04/2015
to
31/03/2016
Disclosure of corporate social responsibility explanatory [TextBlock]
Whether provisions of corporate social responsibility are applicable on
No
company
133

Annual Report

Uploaded by

Copyright:

Available Formats

You might also like

Annual Report

Uploaded by

Document Information

Original Description:

Original Title

Copyright

Available Formats

Share this document

Share or Embed Document

Sharing Options

Did you find this document useful?

Is this content inappropriate?

Copyright:

Available Formats

Annual Report

Uploaded by

Copyright:

Available Formats

MedPlus Health Services Private Limited

Standalone Financial Statements for period 01/04/2015 to 31/03/2016

[400100] Disclosure of general information about company

Disclosure of principal product or services [Table] ..(1)

[400400] Disclosures - Directors report

Details of directors signing board report [Table] ..(1)

Unless otherwise specified, all monetary values are in INR

Textual information (1)

Disclosure in board of directors report explanatory [Text Block]

MedPlus Health Services Private Limited

Amount (In Rs)

Particulars 31st March, 2016 31st March, 2015

Income from Operations (Including other Income) 32,500,434 36,376,939

Total Expenses 75,536,193 70,213,893

Profit/Loss before Tax (43,035,759) (52,019,410)

Profit/Loss after Tax (43,035,759) (52,019,410)

Balance carried to Balance sheet (43,035,759) (52,019,410)

1.1 PERFORMANCE AND FINANCIAL HIGHLIGHTS:

1.2 FUTURE OUTLOOK:

3 CHANGE IN THE NATURE OF BUSINESS, IF ANY:

Date of Board Meetings

1. 22nd April 2015

2. 28th May 2015

3. 8th September 2015

4. 2nd November 2015

5. 13th November 2015

6. 28th January 2016

S. No. Name of Director Designation No. of Board Meetings attended

1. Mr. G. Madhukar Reddy Managing Director 6

2. Mr. Cherukupalli Bhaskar Reddy Director 6

3. Mr. Roy Edwin Campbell II Nominee Director 1

4. Ms. Sudha Ravi Nominee Director 4

The following is the Committee constituted by the Company:

Composition Designation No. of Meetings held No. of Meetings attended

Mr. G. Madhukar Reddy Member 3 3

Mr. Roy Edwin Campbell II Member 3 1

Ms. Sudha Ravi Member 3 3

Composition Designation No. of Meetings held No. of Meetings attended

Mr. G. Madhukar Reddy Member 3 3

Mr. Roy Edwin Campbell II Member 3 0

*Ms. Sudha Ravi Member 3 3

8 DIRECTORS AND KEY MANAGERIAL PERSONNEL:

S. No. Name of Director Designation

1. Mr. G. Madhukar Reddy Managing Director

2. Mr. Cherukupalli Bhaskar Reddy Director

3. Mr. Roy Edwin Campbell II Nominee Director

4. Ms. Sudha Ravi Nominee Director

5. Mr. Atul Kumar Agarwal Chief Financial Officer

6. Mr. Parag Kumar Jain Company Secretary

9 STATEMENT ON DECLARATION GIVEN BY THE INDEPENDENT DIRECTORS:

10 CHANGES IN SHARE CAPITAL:

There was no change in the capital structure during the year.

11 DIRECTOR’S RESPONSIBILITY STATEMENT:

12 NAMES OF THE SUBSIDIARIES/ASSOCIATES/JOINT VENTURES:

The following are the Subsidiaries of your Company:

· Optival Health Solutions Private Limited

· Ritemed Pharma Retail Private Limited